ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000695.1|Fortimicin_2 # 1547 # 2467 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.687	BGC0000695.1|Fortimicin_2 	1547	2467	-	Loose	900	25.0238	msrH	16.67	3005088	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGGGTGATGGCCGTGGTCCGAAGCTGGCGCCGCTGGAGTTGACCGCCGAGGAGCGGGAGGCGTTGCGGGGGCTGGCGCGGCGGCCGAAGACGGCGCAGGCGTTGGCGATGCGGGCGCGGATCGTGCTGGCGTGCGCGGAGGGCCTGTCCAACAGCGAGGTGTCTCGCCGGCTTGGGGTGTCGCTGCCGACGGTCGGCAAGTGGCGTAAGCGGTTCGTGGCCGATCGGGTGGACGGGCTGCGCGACGAGCGGCGTCCGGGTGCGCCACGGAAGATCGGCGACGCCCAGGTCGAGGCGGTGATCACGAAGACGCTCGAAGAGCCGCCACCCAATCAGGACGGTCACTGGTCGACCCGGTCGATGGCCGCGGCGGTGGGGCTGAACCAGACCGCGGTGTCGCGGATCTGGCGGGCGTTCGGCCTCAAACCGCACCAGGTTCAGAGTTGGAAGCTGTCGACCGACCCGCTGTTCATCGACAAGGTCCGCGACATCGTCGGGTTGTACCTGAACCCGCCCGAGGCCGCCATGGTCCTCGCCGTGGACGAGAAGTCGCAGATCCAGGCCCTCGACCGGACCGCGCCGATGCTGCCGATGATGCCCGGTGTCCCGGGCCGGGTGACCCACGACTACGTCCGCCACGGCACCACCAGCCTGTTCGCCGCCCTCGACGTGGCCACCGGCAGGGTGATCGGTCAGACCCAGCGCAAACACCGCCACCAGAGGTTCCTGCGTTTCCTGCGCACCATCGACCGGGCAACCCCGCCCGAGCTGGAGTTGTCGCCGCGCTGGAAGCCGACGTCACCGCCTGGATCGAGGCGTGGAACGCCGACCCGAAACCGTTCGGTGTGGACCAAGACGGCAGACGACATCCTCGAAACGATCGCAGCATACTGCCAACGAATTGACGACTCAGCACACTAG	MGDGRGPKLAPLELTAEEREALRGLARRPKTAQALAMRARIVLACAEGLSNSEVSRRLGVSLPTVGKWRKRFVADRVDGLRDERRPGAPRKIGDAQVEAVITKTLEEPPPNQDGHWSTRSMAAAVGLNQTAVSRIWRAFGLKPHQVQSWKLSTDPLFIDKVRDIVGLYLNPPEAAMVLAVDEKSQIQALDRTAPMLPMMPGVPGRVTHDYVRHGTTSLFAALDVATGRVIGQTQRKHRHQRFLRFLRTIDRATPPELELSPRWKPTSPPGSRRGTPTRNRSVWTKTADDILETIAAYCQRIDDSAH	MEQICFELENIELSYLDKKVLDIDRLAIHQFDRIGIVGRNGAGKSTLLKIIGGIINPSRGKVNQYVEYGYFEQLEGPIAKATNPRLLGKLQVKENASNLSGGEQTRLKLAQLFTHFYDALLIDEPTTHLDQDGISFLIEELKNYYGALILISHDRAFLDELVTTIWEIDEGTVKIYSGNYSDYMRQKQIERTQQVYNHEQFLKEKNRLEKASLEKMKKAEKIAKSTSMSKKESKAKPNRMFESKSKGTSQKSLQRAAKAIEQRINQLQVVEAPNDDYVIHFHSTNNISKLHNKFPIMGDCITLEIDDKVLLKETSFQFPLGKTIAITGKNGSGKTTLIRHIIENGEGITISPKAEIGIYEQMGYQFDEDKTVLSYIKDRSDYDESKIRSVLNAMSFTGNDLKKKVQNLSGGESIRLVLCQLFLGRYNILVLDEPTNFLDIFCIEALESILKEYKGTVIIISHDKKFVEHVSDIVYRIENQKLKLVN	62.96	gnl|BL_ORD_ID|2866|hsp_num:0	3822		
BGC0000695.1|Fortimicin_3 # 2713 # 2937 # 1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.564	BGC0000695.1|Fortimicin_3 	2713	2937	+	Loose	1000	23.8682	MCR-2.2	38.46	3004502	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGTGCGAGGTGAAAATGTGCTGGCGGAGCGCCTTCGTAACGGCAAACAAGAGTCGGGCAAACACCGAAATATTTAGACAAAGGACGATGGCGCGCCGATGTAGAGTGCACGGGCTTGTACGCCCGTCACGGTCCGGGCGGGCCGTGACCTCGGCACTTTGGAGTAACCCATGGTGTTTCGAAGAATCAAAGTCGGACTACCTACTACGCAAGGGACAGTGGTGA	MCEVKMCWRSAFVTANKSRANTEIFRQRTMARRCRVHGLVRPSRSGRAVTSALWSNPWCFEESKSDYLLRKGQW	MTSQHSWYRYSINPFVLMGLVALFLAATANLTFFEKAMAVYPVSDNLGFIISMAVALMGAMLLIVVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNAMQTDQAESKDLMNLAFFVRIIGLGVLPSVLVAFAKVNYPTWGKGLIQRAMTWGVSLVLLLVPIGLFSSQYASFFRVHKPVRFYINPITPIYSVGKLASIEYKKATAPTDTIYHAKDAVQTTKPSERKPRLVVFVVGETARADHVQFNGYGRETFPQLAKVDGLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVDILWRDNNSDSKGVMDKLPTTQYFDYKSATNNTICNTNPFNECRDVGMLVGLDDYVSANNGKDMLIMLHQMGNHGPAYFKRYDEQFAKFTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHEANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNTTFKPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIQ	13.75	gnl|BL_ORD_ID|2727|hsp_num:0	3130		
BGC0000695.1|Fortimicin_4 # 2968 # 4290 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.712	BGC0000695.1|Fortimicin_4 	2968	4290	+	Loose	1080	55.4546	rosB	26.68	3003049	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAGGCAACCGTCGTTCAGGTGGTGCTCGCGGTCGCCGTGATCACCGCCCTCAGTTACCTGCTCGGGCTCGTCGCCCGACGGCTCGGCCAACCGGCCGTCATCGGTCAGATGTTTGCCGGCATCGCCCTCGGCCCCAGCGTCCTGGGTCAGCTGCCGGGGGACCTCGGCAAGGCGCTGTTCCCGATGGCGATCCGGCCCTACCTCACGGTGGTCGCCCAGTTGGCGCTGGTGCTGTTCCTGTTCTACGTCGGTTACGAGCTCAACCGGGGGCTGCTGCGTCAACGGGTGCAGGCCGTCCCGCTGGTCGCCGCGGCCGCGTTCGTGGTGCCGATGCTGCTCGGCGCCGGCTCCACGGTCGCCTTCGCCGACTGGTACGCCGCGACCGGCACGCCAGAGGTGCCGCACGGGGCATTCGTGCTCTACGTGGCCGTCGCACTGTCGATCACGGCGGTGCCGGTGCTGGCCGGCATCATCAACGAGCGCGGGCTGGCCGGCGCGATGACCGGGGTCGTTGCCCTGACCTCGGCCGGGGTCATCGATGCGCTGGGTTGGCTGGCGCTGACCGCCGCGATGCTGCACGGCAAGGTCGGTGGCCAGCGCCCGTGGTCGGTGACCCTGCTCCTGCTGTTGGCGTACCTGCTGGTGATGGTCGTGGTGGCCCGGCCGGCGCTGGGTTGGCTGCGCCGTCAGGCCCTCGCGTCGGGCCGGTCGGCTGCCTCGCTGCTGCCGGTTGCCGCGACGTTCGCGATGGCCTCGGCCTGGGCGACCGGGGCCATGGGCCTGCACGTCATCCTCGGTGCATTCATCGCCGGGCTGATCATGCCGCGAGGCGAGACGGGGCACCCGGATCCGGCGCTGCTGACCGCCGTGGAAAAGGCGGGCAGCGTGCTGCTGCCGGTCTTCTTCGTGGTGTCGGGCCTGTCGACCGACCTGGGTGCGCTACACGCCGCGGACCTGGGGCTGCTCGTGGTGATCTGCGTCGCGGCCACGGCCGGCAAGCTGGGCGGCGGGTCGCTGGCCGCCCGGGTGTCGGGGTTGTCGTGGCGCGAGTCGACGAACATCGGGGTCATGCTCAACACGCGTGGGCTCACCGAGTTGGTGGTGCTCAACGTCGGGCTGCAGGCCGGGTTCGTCAACGGCCGGCTGTACACGGTGTTCGTCCTCATGGCGCTGCTGACGACCGCGGCGACCGGGCCGTTGCTGACCCTGCTGGCACGGCGCGACCCGGCGCCGAAGGCGCCCGAACTGGTCGCCCGCCGACGGGTCGGCCGTTCAGGTGATGTCCATGGGCCGAAAGTGACGGAGAGGACCGTCGAATAG	MEATVVQVVLAVAVITALSYLLGLVARRLGQPAVIGQMFAGIALGPSVLGQLPGDLGKALFPMAIRPYLTVVAQLALVLFLFYVGYELNRGLLRQRVQAVPLVAAAAFVVPMLLGAGSTVAFADWYAATGTPEVPHGAFVLYVAVALSITAVPVLAGIINERGLAGAMTGVVALTSAGVIDALGWLALTAAMLHGKVGGQRPWSVTLLLLLAYLLVMVVVARPALGWLRRQALASGRSAASLLPVAATFAMASAWATGAMGLHVILGAFIAGLIMPRGETGHPDPALLTAVEKAGSVLLPVFFVVSGLSTDLGALHAADLGLLVVICVAATAGKLGGGSLAARVSGLSWRESTNIGVMLNTRGLTELVVLNVGLQAGFVNGRLYTVFVLMALLTTAATGPLLTLLARRDPAPKAPELVARRRVGRSGDVHGPKVTERTVE	MHHSTPLITTIVGGLVLAFLLGSLAHRLRSSPLVGYLAAGVLAGPFTPGFVADTSLAPELAEIGVILLMFGVGLHFSLKDLLAVKAIAIPGAVAQIAVATLLGMGLSHLLGWDLMTGFVFGLCLSTASTVVLLRALEERQLIDSQRGQIAIGRSIVEDLAMVLTLVLLPAFAGVMGNETTSLSQLFTELAITIGKVIAFITLMIVVGRRLVPWILAKTASTGSRELFTLAVLVLALGIAYGAVGLFDVSFALGAFFAGMVLNESELSHRAAQDTLPLRDAFAVLFFVSVGMLFDPMILLREPLAVLASLAIIIFGKSAAAFILVRMFGHSNVYSTHHFCPWRKSVNLPFILAGLGISLGLMSEHGRNLVLAGAILSIMLNPLLFTLLDRYLAKNETMEDLILEEAVEEEKQIPGRFVQSCTVSRLWSGGSLLGAKLHAEGIPLVVIENSRPRVEALREQGINAVLGNAASADIMSLARLDCALVIILTIPNGYEAGEIVASARIKRPDLEIIARAHYDDEVVYISVRGANQVVMGEREIANSMLNMLKIETLTEEDKRPLCPI	78.15	gnl|BL_ORD_ID|476|hsp_num:0	507		
BGC0000695.1|Fortimicin_5 # 4629 # 6635 # 1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=4bp;gc_cont=0.690	BGC0000695.1|Fortimicin_5 	4629	6635	+	Loose	1200	29.261	TaeA	31.03	3003986	protein homolog model	n/a	n/a	pleuromutilin antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGACTCTCGACTTCCTGCGTGTTCGGAATCAACGTGTGCGCCAGAAGTGGGCCACGCTCGACGGCACCCGCGACGGTGCCGCCCCGGAGGAGAACCTCGACGGGGTCAAGGACCCGGACTTCCTCGCGCTCGGCCTGGGCGCGACGAACATGATGGCAATGTTGTGGTCGCTGGCCCTCGGCCGGCGAGTGGTGGGCGTGGAGATGCGCGGCGACCCGTCGCTGGGCGTCCACTGGAACATCCGCGAGGACCTGTTCCACCACTGGGGCCTCATCGACAAGCTGATGCTGGAGCGTTACGGCGAGGAGAACCTCCCCCACCGCGGCGACGGCAAGTTGTTCCGCCTCGCCGAGTGCTTCTACGACCCGGGCACCGCCGCCGGCGCGGTCACCGCCGACGAGGTGGTGACGGGCTTCCTCGACACCCTCATCGGCGAACCGTCGCACATCGGCGGCCGCATCTTCTACACCGAGTTCATCGACGACCGCTGGCAGGAGGGCAAGCCCAACCGCGTCGTCACCGTCCTGGAGCCGCCGGCGCCCCCGGACAAGCCCGACGTGTCCAAGGTGGGCCGCACGGCGCTGGAGGCGCTGGAGGGTCCGTCGACGTTCCAGTGCGCCGCGTCCGAGGTCATGGTGCTCATGCGCCGCTACCTCGAGATGATTGAGCAGATGGACCTCGAGCGCGGTGTCACCCCGCGGGTGCGCCTGTTCACCTCGCACCGGGTGGTGTCCACCGGCACCGACGAGGACGCCGGCTACCTCAGCTGGCTCCGCCGCGAGGAAGGGTTCGTCAACTGCCCCGACGGGCGCAAGCGCATCCAGATCGAGGCCGTGCGCGAGTTGGACTACAACGGCAAGTTCCGCCGGGTCCGCGTGCCGGGTAGCAAGACCATCGACCTCGGCGTGCCGAAGCTGTTCATGATCGCCCAGGGGTTCAACAGCAGCGACGCGGAACGGCTCGGCTTCAAGCAGGAGGACGTCAAGGTCGACCACCACGACGGGCGTGGCGCCGTCGTCGCCCAGGCCGACTACCTCGCCGGGCTGCTGGAGATCCTCGTCGACGGGCGGCTGCGCCGCCGCATCGCCTCCGACTTCGACAAGGAGGGCAACGAGTACTGGGTCCGCCAGATCGCCGTCGGCCACGAGGACGACGCCGAGGTCGGGTGGATCCTGGTGCAGGTGCCCGACTACAAGACCTTCGACCCGATCCTCGCGGGGCTCGTGCCGCCCGGCACCCACCGCAAGTCCAACGAATACCGGGCCGGCGTCCAGCACCTCATGCGCGAGTACTACCTGGAGCAGGTATCGCTGATCACCGAGATGCCGGTCGCAGAGCTGGAGAAGGTCCAGTTGCCCTACGGGCCGAAGCTGTTCAGCCTCGTGGAGAAGGCCGGCGTCGACGCCCGCGTGGCGGTCAACGGGGTCGTGGGCGGTGACACGTTCGGCAACGGGCATTTCCTCACCAGCGGCGGGGCGATTACCGGCATGATCGGGCACGCCTACCGGGTGCTGAAGTACTGGGAGGCGATCGACGCCGGCGTCGAGCACGACGTGGCCGTGCGCGAGCTCGCCGACGGCATCAAGCAGGACACGGACTGGTGGTTCCACGTCAGCGCCCAGGAGTTCAGCCAGGCCGTGCCGATCAACTTCGGCGCCGAGCGGATCGCCAAGATCGAGAAGGCGACCGGTCGTGACTCGGCGGCGCGCGCCAGCACCATCGACGCCACCCGCCGGCACCGCCACTCGCTCGTCCCGCTGGACCCGTCGGACTGGCGACGGCTGCTGGTGCGCAGCGGCCGCATGCACGCCTTGGCGTTGCCGCCGATCCAGGACACCCACCCCGACCTGCGTGGTCCGGACATGATGCCGATGGACGCCAAGGCGACCGCCTGCATGGGTGGCGACGGCATGACGGGCAACGGCACGACGGGCAACGGCACGACGGGCGACGGGATGGCCGACGACGGCGCGATGCTGGCCGACATGGAGGTAACAAGCCGATGA	MTLDFLRVRNQRVRQKWATLDGTRDGAAPEENLDGVKDPDFLALGLGATNMMAMLWSLALGRRVVGVEMRGDPSLGVHWNIREDLFHHWGLIDKLMLERYGEENLPHRGDGKLFRLAECFYDPGTAAGAVTADEVVTGFLDTLIGEPSHIGGRIFYTEFIDDRWQEGKPNRVVTVLEPPAPPDKPDVSKVGRTALEALEGPSTFQCAASEVMVLMRRYLEMIEQMDLERGVTPRVRLFTSHRVVSTGTDEDAGYLSWLRREEGFVNCPDGRKRIQIEAVRELDYNGKFRRVRVPGSKTIDLGVPKLFMIAQGFNSSDAERLGFKQEDVKVDHHDGRGAVVAQADYLAGLLEILVDGRLRRRIASDFDKEGNEYWVRQIAVGHEDDAEVGWILVQVPDYKTFDPILAGLVPPGTHRKSNEYRAGVQHLMREYYLEQVSLITEMPVAELEKVQLPYGPKLFSLVEKAGVDARVAVNGVVGGDTFGNGHFLTSGGAITGMIGHAYRVLKYWEAIDAGVEHDVAVRELADGIKQDTDWWFHVSAQEFSQAVPINFGAERIAKIEKATGRDSAARASTIDATRRHRHSLVPLDPSDWRRLLVRSGRMHALALPPIQDTHPDLRGPDMMPMDAKATACMGGDGMTGNGTTGNGTTGDGMADDGAMLADMEVTSR	MNILTVEQVTKSYGDKILFQDASFGMEDQDKIGIIGVNGTGKSTFLRVIAGLEPPDSGKISMGNRIRVRYLAQNPEFDPDKTVLQQVFEGDLPEMKAVREYTETMELLELHPSHEELQQKLLKLNQTLETLQAWQLESDAKTILSKLGIRNYEAKMGTLSGGQRKRVALAAALIQPSDLLILDEPTNHIDNESVAWLEQYLQKRRGALLMITHDRYFLDRVANVMLELDHGRLFRYEANYSRFLELKAEREEREAASEQKRQNLLRSELAWIRRGAKARTTKQKARIERFEKLKDQEMVHSSGELDVSVASTRLGRKILEIEGLRMKIDDKTLIQDLSYIAVPEDRIGIVGPNGSGKSTLLNLIAGRIQPGGGEVVLGPTVKLGYFTQEHQEMDGSQRVIEYIKDEAEVVRTADGSAITAAQMLERFLFPPALQWTPIAKLSGGEKRRLYLLRVLMSAPNVLLLDEPTNDLDIQTLSVLEQYLDEFPGVCIVVSHDRFFLDRTVDKIMAFEGDGQIRVHVGSYSEYAEWMQRHGGEASGSKAEASIAKSASGSSDGTDSDSAKEAPRERLKFSYKEQREFDQIDGLIEDTESKLASIQSEMETAGSDAARLQELMKAQEETERELEHLMERWTYLNELAEKIEQSKKS	103.09	gnl|BL_ORD_ID|2292|hsp_num:0	2522		
BGC0000695.1|Fortimicin_6 # 6632 # 8143 # 1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.708	BGC0000695.1|Fortimicin_6 	6632	8143	+	Loose	990	157.532	qacB	27.47	3003047	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGAAGCTCGGGCAACCGAAGGGCGACTCGTTCGGCAGCCTCGCCGAGACGGTCCAGCCCCGGCGGCTCATCGTCGGCCGCTACCGCTCCCTGCGAGAACGGCAGCTGGCGCTGCTCGTGGTCTGCGCGGGCGCGCTCGCCATCGTGATCGACACTTCGGTGGTCAACGTCGCCCTGCCGTTCCTCGCCAAGGACCTGGACTTCTCCGCCTCGGAGCTGTCCTGGGTCGTCAACGCCTACGTCATCCCGTTTGGCGGACTGCAGCTGTTCGCCGGCCGGCTCGGCGACCTCATCGGGCCGAAACGGCTGTTCATCGGTGGCATGGCGCTGTTCACCGCCGCGTCGCTGGCCTGCGGGCTGGCGCAGAGCGGGGGAATGCTCATCGCCGCCCGGTTCGCGCAGGGCGTCGGCGGCGCGTTGGCCGCCGCCGTCGTGCTGAGCATCGTCGTGGCGATGTTCCCCAAGCCGGGGGAGCAGGCCAAGGCGATCGGCCTGTATTCGCTGGTCTCCTCGGTCGGTGCCGCGCTCGGGCTGATCGGCGGCGCTGCCATCACCGAGGCGCTCGGCTGGAACTGGGTGTTCTTCGTCAACCTGCCGATCGGCGCAGCGGCCATCGTGCTCGGGTACCGGCTGCTCGACGACGAGCGGGAGGCGGGGGAGCGCGGCATCGACGCGCTCGGCGCCGTACTCATCACCGCCTGCCTCATGCTCGCCGTCTACACGATCGTGCAGACCTCCGGTACGGAGGGCAGCGCCGTTCGTACCTGGGTGCTGACCGGCGTGTCGGTGCTGCTGCTCGTGGCGTTCCTCGTGCGGCAGGCCCTCGCCAGCAACCCGCTGGTCCCACTGTCGATCTTCCGAGCGCGCAACGTGTCGGCGGCGAACCTGGTCCAGGCGCTCATGGTCGCCGGGATGAGCGGCATGTTCTTCCTCGGCGCGCTCTACCTGCAGCAGGTGCTGGCGCTCAGCGTGCTCGAGGTGGGCTTTGCCTTCGTGCCGACCGCGACCGTCGTGGCCATCTGCTCGATCAAGGTCGCGCCGAAGCTCATGAAGAAGGTCGACGCGCGTACGGTGCTGCTGCCCGGCCTGCTGTGCATCACCGCGGGCCTGCTGCTGCTGAGCCGGGTCCCGGCCGACGGTGACTACTTCACCGACGTGCTGCCGGCGATGCTGCTGCTCGGCGTCGGCGCCGGGGTGGGCTACCCGGCGGCGCTCACCATCGTGCTCGCCGACGCCACCACCAGCGACCGGGGCCTGCGTTCCGGCCTGGTCAACACCACTCAGCAGTTCGGCCCGGCGATCGGGCTCGCGGTCCTGGCCACCCTGGCCGCCCACCACACCGGTGGCCTGCTGGGTGACGGCCGCCCGACCGTCGAAGCGTTGACCGCCGGGTACCACCTGGCGTTTCTGGTCGGCGCGGGCTTCGCCGCGGCCGGCATCGTGCTCACGCTGCTGGTGGTGCAGCCGGCGGTGCCGCGGAGCGCGCCCAACGTGCTCGACGAGGCGCGTTAG	MKLGQPKGDSFGSLAETVQPRRLIVGRYRSLRERQLALLVVCAGALAIVIDTSVVNVALPFLAKDLDFSASELSWVVNAYVIPFGGLQLFAGRLGDLIGPKRLFIGGMALFTAASLACGLAQSGGMLIAARFAQGVGGALAAAVVLSIVVAMFPKPGEQAKAIGLYSLVSSVGAALGLIGGAAITEALGWNWVFFVNLPIGAAAIVLGYRLLDDEREAGERGIDALGAVLITACLMLAVYTIVQTSGTEGSAVRTWVLTGVSVLLLVAFLVRQALASNPLVPLSIFRARNVSAANLVQALMVAGMSGMFFLGALYLQQVLALSVLEVGFAFVPTATVVAICSIKVAPKLMKKVDARTVLLPGLLCITAGLLLLSRVPADGDYFTDVLPAMLLLGVGAGVGYPAALTIVLADATTSDRGLRSGLVNTTQQFGPAIGLAVLATLAAHHTGGLLGDGRPTVEALTAGYHLAFLVGAGFAAAGIVLTLLVVQPAVPRSAPNVLDEAR	MISFFTKTTDMMTSKKRWAALVVLAVSLFVVTMDMTILIMALPELVRELEPSGTQQLWIVDIYSLVLAGFIIPLSAFADKWGRKKALLTGFALFGLVSLAIFFAESAEFVIAIRFLLGIAGALIMPTTLSMIRVIFENPKERATALAVWSIVSSIGAVFGPIIGGALLEQFSWHSAFLINVPFAIIAVVAGLFLLPESKLSKEKSHSWDIPSTILSIAGMIGLVWSIKEFSKEGLADIIPWVVIVLAITMIVIFVKRNLSSSDPMLDVRLFKKRSFSAGTIAAFMTMFAMTSVLLLASQWLQVVEELSPFKAGLYLLPMAIGAMVFAPIAPGLAARFGPKIVLPSGIGIAAIGMFIMYFFGHPLSYSTMALALILVEAGTASLAVASALIMLETPTSKAGNAAAVEESMYDLGNVFGVAVLGSLSSMLYRVFLDISSFSSKGIVGDLAHVAEESVVGAVEVAKATGIKQLANEAVTSFNDAFVATALVGGIIMIIISIVVYLLIPKSLDITKQK	97.86	gnl|BL_ORD_ID|521|hsp_num:0	558		
BGC0000695.1|Fortimicin_7 # 8169 # 10031 # 1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=4bp;gc_cont=0.710	BGC0000695.1|Fortimicin_7 	8169	10031	+	Loose	300	25.409	AAC(3)-IIb	36.36	3002534	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGGGGGTCACCGACCCCGACTTCCTCACCCTCGGGATGGGTGGCACCGGCATGATGTCCATGCTGTGGTCGGTGGCCATGGGCCGCCGCGCCGTCGGTGTGGAGCTGCGTGGTTCGCCCTACGTGTCGGTCATGCGCTGGACGGTGTGCGAGGACGTGTACCACCACCTCGCCCTGATCGACCGCATGATGCTGGAGCGCTACGGCGAGGAGGGCGTCCCCCCGCCGTGGCGACGGGTGCTGCTCAAGCTGGCCGACTGCTTCTACACGTCCTACACCGACCCGGGCTCGGTGCGCGGCGACGAGATCATCACCGGCTTCGCCGCCGACTCGCACATCGGTGGCATCGCCCGCTACCACGAGCACATCGACGACCGGTTCCGCGACGGCCGGCCGCACCGCGAGGTGTCGATGCCGGAGCCGATCGTGGCGCCCACGCAGGTCGACCCGGCCCTGCAAGGTCGTCCGATGCGCGAGGTGCTCGACAGCCCGTCGGCCTTCCAGGTCGGCGCCGAGGAGCTGCTGGTGGTACTGCGCCGCTACCTCGAGGGCATCGAGGCGATGGACCTGGCGCGCGGTGTGCCGCCGCGGGTGCGCATCCTGAACTACCACCGGGCGGTCGCGGTGGACGAGAACGAGCCTTCGGGGTGGCGGCGGATGCTGCCGCGGCGGCGGGCCCACACCGAGGAGGGCTTCGTCGTGGGGCCGGACGGTCGGGTCCGCGTCCGGGTCGAGGCGGTGCGCGAGCTCGACTACAAGGGCAGCTTCCGCCGGGTCCGGGTGCCCAACAGTCGGGTCATCGATCTGGGTACCCCGCGCCTGTTCATGATCGCGCAGGGACTGGACAGCCGCGACGCCCGCCGGCTGGGGTTCCGGCAGCAGCCGGTGCTCATCGACCACGGCGACGGGCGCGGCGCCGTTCCGGCCGAGACCGATTACCTGGCCGGCAACGTCGACATCTACCTCGCCGACCGGATCCGGCACCGGGTGGCCTCCGACTTCGACGCCGCGGGCAACGAGTACTGGGTGCGCCAGGTTGCCATCGGCCACGAGGGCGACGCGCAGATCGGTTGGGTCCTGGCCGAGGTTCCTGAGTACAGGACCTTCGACCCGATCCTGGCCGGGCTGGTGCCGCCGGGCACGCCGAAGGGCTCCAAGCGGTTCTTCGCCGGGCACCAGTTGCTGCTGCGGCAGTACTTCCTCGACCAGGTCTCGCTCATCACCGAGATCCCGCGCGCGGAAATGGAGCGCAACCAGCTCTCCTACGGGCCGAAGCTGTTCACCATCGCCGAGCGGGTCGGGCAGGACGCCCTCGTCGCACCGAACGGCGTGGTGGCGGGCGACTCGTTCGGCAACGGGCACTTCGTGCACAGCGGCGGGGTGATGACCGGCATCGTCGGTCATGCCTGGCGGGTGCTGCGCTTCTGGCAGGCCGTCGACGCCGGCACGGACGAGCGCACGGCGATCCGGCAGTTGGCCGACGAGATCAAGGCCGACACGGACGACTGGCTGGCGCACAGCGCCGAGCTGTTCGCCCGGCCGACGCCGCGGGCGACCGTCGCGGAGCCGCAGGAGCGGGAGCGGCAGCGGGCCCTCGCCGAGGCGACCCGCTACCGCCGCTCGATCGTGCCGCAGCGCTACCCGGACGAGTGGAGCAGGATCCAACTGCGTACCGGCCGGATCTACGCATACGGCCTGCCGCCTATCGACCCGGTCCCGCCCGCGCTGCGCACGGAGCCGGCGGCCACTTCCATGGCATCCGGTTCGATGACTCGCACCGGCGGGTCGGGCGGCATGTCATCCGATGCCATGGCGACCAACGAAATGGCAGCGGACGATATGGCTGGCGCAACACGGATGTGA	MGVTDPDFLTLGMGGTGMMSMLWSVAMGRRAVGVELRGSPYVSVMRWTVCEDVYHHLALIDRMMLERYGEEGVPPPWRRVLLKLADCFYTSYTDPGSVRGDEIITGFAADSHIGGIARYHEHIDDRFRDGRPHREVSMPEPIVAPTQVDPALQGRPMREVLDSPSAFQVGAEELLVVLRRYLEGIEAMDLARGVPPRVRILNYHRAVAVDENEPSGWRRMLPRRRAHTEEGFVVGPDGRVRVRVEAVRELDYKGSFRRVRVPNSRVIDLGTPRLFMIAQGLDSRDARRLGFRQQPVLIDHGDGRGAVPAETDYLAGNVDIYLADRIRHRVASDFDAAGNEYWVRQVAIGHEGDAQIGWVLAEVPEYRTFDPILAGLVPPGTPKGSKRFFAGHQLLLRQYFLDQVSLITEIPRAEMERNQLSYGPKLFTIAERVGQDALVAPNGVVAGDSFGNGHFVHSGGVMTGIVGHAWRVLRFWQAVDAGTDERTAIRQLADEIKADTDDWLAHSAELFARPTPRATVAEPQERERQRALAEATRYRRSIVPQRYPDEWSRIQLRTGRIYAYGLPPIDPVPPALRTEPAATSMASGSMTRTGGSGGMSSDAMATNEMAADDMAGATRM	MNTIESITADLHGLGVRPGDLIMVHASLKAVGPVEGGAASVVSALRAAVGSAGTLMGYASWDRSPYEETLNGARMDEELRRRWPPFDLATSGTYPGFGLLNRFLLEAPDARRSAHPDASMVAVGPLAATLTEPHRLGQALGEGSPLERFVGHGGKVLLLGAPLDSVTVLHYAEAIAPIPNKRRVTYEMPMLGPDGRVRWELAEDFDSNGILDCFAVDGKPDAVETIAKAYVELGRHREGIVGRAPSYLFEAQDIVSFGVTYLEQHFGAP	230.48	gnl|BL_ORD_ID|870|hsp_num:0	925		
BGC0000695.1|Fortimicin_8 # 10085 # 11803 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.732	BGC0000695.1|Fortimicin_8 	10085	11803	+	Loose	700	26.9498	DHA-12	30.0	3002143	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	ATGGCGCCGCGGGCGGCCGCGCGAGCATCGGAGGACGGCGTGACGACGAGCACCGACGCGAGGTACGGTCCCGAACCGACCGACGGCGACGTGCGCACGGAATACGACGTGTGTGTGGTCGGCAGCGGCGCGGCCGGCGCGACCGTCGCGTGGCTGCTGAGCCGCGCCGGCCTCTCCGTCGCCGTCGTCGAGCAGGGCGGCCACGTCACCGCCGACACCAGCTACGACGACATCCTCGCCGCCGCCGAATCGGCCTGGGTGCGCCAGTCCAACGGCACGTGGGGCAAGGTCGGCTCGCCGTGGACCACCTGCAACGTCGGCGGCGGCACCGTCTTCTACGGCGGCGTGCTGTTCCGCCACCGCCCCATCGACTTCGACCCTGAGCGGGTGCTCGGACAGGCCGACCTGCCGCTGCGGTGGCCATGGGACTTCGACGAGCTGGAGCCCTACTACACGGCCGTCGAGGACATCATCGGCGTGGCCGGGCTCGCCGGGGCCGACCCCGGCATCCCGGCACGCTCCGCGCCGATACCCGCTCGTGCCGGTGCCCACCTCGCCCGAGGGCGCCCGTTGATCGCCCGGGCCGCCAAGGCGCTCGGTTGGCACCCGTTCCCCACGCCGCTGGGCGTGCTCACCGACGCCTACCGAGGCCACCACGGCTGCGTGGCCGACGCGCCGTGCATCTCGCGTACCTGCCCCGTGGGCGCGAAGGGCGATGCGGTCAACCGTTTCCTCACCCCCGCGCTGCGCGCCGGTGCCCGGCTGTTCGCCGGCCTCAAGGCCGTCGCGCTCCTCGGCGACGAGCGCCACGACGCCCGCGCGCTGCGCTGCGTGAGGGTCGACACGGGCCGCTGGTACGAGTTCCGCGCCCGCCAGTTCGTCGTCTGCGGCAACGCGGTACAGAGCGCGGCGCTGCTGCTGCGTTCCACCACCGAACGACACCCGCGCGGGCTGGGCAACTCCCACGACCTGGTCGGTCGAGGCCTGTGTTTCAAGCTCAGCGAGTACCTCGTGGGCTACGGGCACCGGGGCAGCGACGAGCCGCCGCGCAGCGAGGTCATGGGCCTCGGCCCAGTATCCACGGCCGCCATCACCGACTTCTACGAGGACCCCGCCGCCCCGGGCGGGCTCGGCGGCGTGCTCTACGAGGTACGGCCCGAGCGCACGTACCGGGTGCGTACCAACGAGCAGCTGCTGCGCATCGAGGCGCTGGTGCCCGACGAGCCGCAGCCGACCAACCGGGTGCGGCTGGGCACCGGCACCGACTGTCACGGCGTCACCGACATCGTCATGGATTACCAGGCGCACCCACGGGACCTGGCCAGGCTGGAGTACATGCTGCGCCGCGGCGAGGAGCTGTTGCGCGCAAGTGGGTGCAGCGTGGTGGTACGCGAGCCGTCCGGCTGGGAACTGGGCAGCGGCCACCTGCACGGCACCTGTCGAATGGGCACCGACCCGGCCACCAGCGTCACGGACCCGAACGGGCGGCTGCACGACGCCGACAACGTCTACGTCGCCGACGGTGCGCTGCTGCCGTTCCCCGGCGCGGTCAACCCGACGCTGACCATCCAGGCGGTGGCGCTGCGAGTGGCACAACGCCTGCTCGTCGACCGGTTCGGCGCCCCGGCGACCCCCGTCGGCGAGGTGGTCAGCCCGCCGACGGTTGTGGTGCCGGCCCAGCGCTCCAGCGCTCCCCCAGCAACGCTGCCACACGGCTGA	MAPRAAARASEDGVTTSTDARYGPEPTDGDVRTEYDVCVVGSGAAGATVAWLLSRAGLSVAVVEQGGHVTADTSYDDILAAAESAWVRQSNGTWGKVGSPWTTCNVGGGTVFYGGVLFRHRPIDFDPERVLGQADLPLRWPWDFDELEPYYTAVEDIIGVAGLAGADPGIPARSAPIPARAGAHLARGRPLIARAAKALGWHPFPTPLGVLTDAYRGHHGCVADAPCISRTCPVGAKGDAVNRFLTPALRAGARLFAGLKAVALLGDERHDARALRCVRVDTGRWYEFRARQFVVCGNAVQSAALLLRSTTERHPRGLGNSHDLVGRGLCFKLSEYLVGYGHRGSDEPPRSEVMGLGPVSTAAITDFYEDPAAPGGLGGVLYEVRPERTYRVRTNEQLLRIEALVPDEPQPTNRVRLGTGTDCHGVTDIVMDYQAHPRDLARLEYMLRRGEELLRASGCSVVVREPSGWELGSGHLHGTCRMGTDPATSVTDPNGRLHDADNVYVADGALLPFPGAVNPTLTIQAVALRVAQRLLVDRFGAPATPVGEVVSPPTVVVPAQRSSAPPATLPHG	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVEAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKEMSLNDPAAKYRPELTQPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLHFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTTRILSPLGLSHTFITVPESAQSQYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIVNGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	150.92	gnl|BL_ORD_ID|799|hsp_num:0	846		
BGC0000695.1|Fortimicin_9 # 11817 # 12680 # -1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000695.1|Fortimicin_9 	11817	12680	-	Loose	590	25.0238	HERA-4	39.13	3004819	protein homolog model	n/a	n/a	penam	antibiotic inactivation	HERA beta-lactamase	ATGACCGGCACCGTGCCGGCATCGGCCGGCACGCGCTGTGCGGCGCACCCGGACACCGACGCGGTGGTGGCCGCGCCCGGCGACTTCTACCGTCGCTGGGTCACCGACAACCCGCTGCTCGGCGAGCGGCGGGCACTGCTGGCGCGATGGCTGGACGACCCGACGCCGCGGGAGGAGATCGCCGAGGCGCTCGGGCTGCCGCTGGGGGCGCTGCTGCGCGCCTTCAACGACACGGCCCCGCTCGACGCGCCGGTGCCGTTCCGCTACCGGGGCGTCCGGTTCGCCGTCACCGGCATGGCGGGGGTGTGCGACGACATCGTCGGCGACCGGTTCCCCCGCTTCGGCACGCCGGTGACGCTGCGCTGCCACCTCGCGGAGCCGAACCTGCTGCCGCAGGCGATGTTCGAGGCGGCCGATTGGAACTTCATGGACGCCGACCGCCCCGGGTTCCTCGGCTACGCCTACGGGGTGCGGGAGGGCGACACGCTTTACCTGGCCGGCATGCAGAGCGACCTGGCCGCCCGGTACAGCTATCTGTTCCAGGGCCGCGGCGAGGGCACCGACGTGCGGATCGGGGACGAGGTGGCGTTCCAGCCGACCGAAGAGCTGGTTGCCCGGTTCGGCGACTACGTGCCGGTGCTGCGGCGTACCTTCCAGCGGTACTGGATAGACGTGCTGCTCGGCGCTGTGGCCGCGTGGGCAGCCACCGAGCCGGCGCTGCGCACGCTGGGCCTGCTGTGGTTCGACCTGGAGCCGCAGGAGGACGCGCACGGGCACCTGGTGAACCGGGTGTACCGGCAGCTGCCACAGCGGCTCGCCGCCGACGTGCGGCACGTGCACGCCGACGGACGGTGCCACAGCTAG	MTGTVPASAGTRCAAHPDTDAVVAAPGDFYRRWVTDNPLLGERRALLARWLDDPTPREEIAEALGLPLGALLRAFNDTAPLDAPVPFRYRGVRFAVTGMAGVCDDIVGDRFPRFGTPVTLRCHLAEPNLLPQAMFEAADWNFMDADRPGFLGYAYGVREGDTLYLAGMQSDLAARYSYLFQGRGEGTDVRIGDEVAFQPTEELVARFGDYVPVLRRTFQRYWIDVLLGAVAAWAATEPALRTLGLLWFDLEPQEDAHGHLVNRVYRQLPQRLAADVRHVHADGRCHS	MKKITPLFVIAFLTLIALLAPAQASVTPDMTDFLRQQEQRLHARIGMAVVNAQGETVFGYRQDERFPLTSTFKTLACAALLERLQKNGGSLDEQVTIPPDALLDYAPVTKNYLAPATISLRMLCAAAVSYSDNTAGNRILTYLAGPDAVTQFMRGIGDHVTRLDRTEPTLNEATPGDARDTSSPQKMAAGLQKILTSPPLISANRATLAQWMRDDKVGDALLRAALPKGWAIADKTGAGGYGSRAIIAAVYPPERPPFYVAIFITQTEASMKMANETTAEIGKQLFAGQP	98.97	gnl|BL_ORD_ID|2608|hsp_num:0	3613		
BGC0000695.1|Fortimicin_10 # 12677 # 14116 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.775	BGC0000695.1|Fortimicin_10 	12677	14116	-	Loose	300	26.9498	AAC(3)-VIIIa	32.91	3002542	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGTCGATGCGGCAGCAGCCGGACCTGGTGGTGCTCGGCGGCGGCGGCGCGGGCGCGATGGCAATGCTGTGGACGCTCGCGGCGGGGCGGCGCGCCGTGGGCGTGCCCGGCGCCGACCCGCCCAGCGACCCGCTGCTCGGGCCGGGCGCCACGTGGTGTCTCCCGGCCGGCGTGCACCGACACCTGGAGCTGCTCGACCGGCTCTTGCTCCGCCGCTACGGCCCCGACGGCGTGCCGGCCCGCGCGGACGGCTCCCGCTGGCGGCTCGCCGACGCGCTGCGCCCGACCGATCCTGCTCTGGCGGGCGGCGCCGTCGAGGTACGCGAGGAATGGACGGACGGGGAGTCACGGGCGACCGTCACCGCCACCTGGCCGGCAGTACTGCGCGTGCCCGCCACCGAACTGCTCGCCGAGCTGTGGGGCTACCTGGCCGCGGTGGAGGCGACGGACCGTCACGCCGGGCGGGCGCCCCGGGTGCGGGTGCTGTCCGGGCACGCCGTGGCCGGACAGTCCATGGCGGGGCGGGTGCGGCTCACCGCGCCGGACGGAGCCACGGTCGACCTCGGCGACTCGGAGCTGGTGCTGCTCGACGACCACCCCGCCGGGGCCGCCGCCCGGGCCTGTGGCGTCACGGCCGCGCCACTCGTCGTGGACCACGGCGACGGGCGGGGCCCTACCCTGGCCCGCGCGCACCTGGTCGTGGGTGCCCTGGATACTTCGGTGGGTGACCTGTGCCGCCGCCGGGTCGCGCCCGCGTTCGATGAGGACCACGACGAGTACCGGGTGCGGCAGGTCGCTGTGGGCCGCGGCCCGACCGGCATGCCCGCCTGGCTGGCGGTGCAGGTGCCCGAGTACCACGTCTTCGACCCGGTCGAGGCGGGGCTGGTGCCGCCCGGCACCCCGCCCGACTCCCCTGACCACCTCGACGCGGTCCGGCTGTTGGTACGCCGGCTGTTCGTGACGGCCGCGGCGGAGCTGCTGCAACGGCCGGAGGCGGCGCTGGACGGCGCGATTCGCGGCGGCCCGGACCGGCCCCGCCTCGTGTCGGCGACGGCCTGGCGCCCGGTCGGCCCACCCTCGGACGGCGCCGGCCAGCTCATCGCGGTGGGTGACACGGTGGGCGGCGGGCATCCGCTGCATCCGCTGCGCCCCGTCACCGGTCCGTTCCGCCACGGCCACCGGGTCCGCCGCTACTGGCGGCGACGCGCGGCGGGCACCGGGGCGGGGGAAGCCGCGCTCGCCCTGGCCGTCGAGGTGGCGGCCGACACCGCCGAGTGGATCAACGCCAGCATTTCCGACTTCGCCGAGCCACCGCAGTTCCACTTCAACGCCGACTGCTTCGCCGAGCTCGCCTACGCCCGGGCGCACCGGGAGCACTTCGCGGCGCTGGAGGCCGGGCGGCCGGCGCACCCGGCACTGCTCGACGGGGTGCCGCGATGA	MSMRQQPDLVVLGGGGAGAMAMLWTLAAGRRAVGVPGADPPSDPLLGPGATWCLPAGVHRHLELLDRLLLRRYGPDGVPARADGSRWRLADALRPTDPALAGGAVEVREEWTDGESRATVTATWPAVLRVPATELLAELWGYLAAVEATDRHAGRAPRVRVLSGHAVAGQSMAGRVRLTAPDGATVDLGDSELVLLDDHPAGAAARACGVTAAPLVVDHGDGRGPTLARAHLVVGALDTSVGDLCRRRVAPAFDEDHDEYRVRQVAVGRGPTGMPAWLAVQVPEYHVFDPVEAGLVPPGTPPDSPDHLDAVRLLVRRLFVTAAAELLQRPEAALDGAIRGGPDRPRLVSATAWRPVGPPSDGAGQLIAVGDTVGGGHPLHPLRPVTGPFRHGHRVRRYWRRRAAGTGAGEAALALAVEVAADTAEWINASISDFAEPPQFHFNADCFAELAYARAHREHFAALEAGRPAHPALLDGVPR	MDEKELIERAGGPVTRGRLVRDLEALGVGAGDTVMVHTRMSAIGYVVGGPQTVIDAVRDAVGADGTLMAYCGWNDAPPYDLAEWPPAWREAARAEWPAYDPLLSEADRGNGRVPEALRHQPGAVRSRHPDASFVAVGPAAHPLMDDHPWDDPHGPDSPLARLAGAGGRVLLLGAPLDTLTLLHHAEARAEAPGKRFVAYEQPVTVGGRRVWRRFRDVDTSRGVPYGRVVPEGVVPFTVIAQDMLAAGIGRTGRVAAAPVHLFEAADVVRFGVEWIESRMGGAAGGA	167.48	gnl|BL_ORD_ID|471|hsp_num:0	501		
BGC0000695.1|Fortimicin_11 # 14239 # 15546 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.744	BGC0000695.1|Fortimicin_11 	14239	15546	-	Loose	700	45.0542	LpsB	22.58	3005051	protein homolog model	n/a	n/a	peptide antibiotic	reduced permeability to antibiotic	Intrinsic peptide antibiotic resistant Lps	ATGCCGAGCTCTGACCCGGCCGTTATGCACGTGCTACGGCTGACGCCGTACTACTACCTCGCGGGTCGCGAGCTGACCCACCGGGAGCTGCAGTACGAGCCGATCGGCGGCATGCAGGTGCAGATCATGCAGACCACCGAGCAGCTGTCCGAGCTGGGGATCCGCCAGACGGTGGTGTTCCCCCAGCGGCCGGGCATGCCCCGCACCGTGCAGCTCGACGCGCGCACCAGCTTCGAGCTGCTGTCACCGCCGGTGGCGCCGATCCCCACTCGGTCGAAGGGCTACGTGGGGCTGCTGGTGTCGTGGGGGCTGGCGCTCGTCGCCTGGTGCGTCAGGCAGCGGCTGCGGGGGCAGCACCGGCAGTACTCGGTGATCCACATGCACTGCAGCGAGCTGCCCTGGACGTTCCTGTTCGCGGTGCTCGCCCGGTGGCTGCTGCGCCGGCCGCTCGCGCTGACGGTGCACTGCAGCGCCCTGGTGACGTTCCATCCGGAGACGCTGGCGGGCCGGCTGCTCATCGGGCCGGCCCGGTTCTTCGAGCGGGTCGCGATACGCCGGGCGGAGGCGGTGGTGGTGCTGACGCAGCGGGTCCGCGACGCCTACGTCGGGCTGGGCCTCACCGACGCCGAGCGGGTCCACGTGGTGCCGGACGGGGTGCGGCTGGCCGACTTCCGTCCGGACCGCGCCGCCCCGGCCGGAACCGCCGAGGCCGAGTCCGAGCCGATCGTGCTCTACTGCGGACGCTTCGCACCGGAGAAGGGCTGGGCCGACTACGTCGACGCGGCCGGGCTCCTGGTCGCCGAGGGTACCGACGCGCGGTTCGTCATGTGCGGCGACGGCAACGAGCTGGCGCGGTGCCGGGTCCAGCTGCGGCGACTGGGCATCGAGGACCGGGTGGAGCTGCTGGGCCACCTGGACCGGCCGGACATCGCCCGGACGATGCGCCGCGCCGCCGTGGTGGTGATCCCGTCCCGGCACGAGGAGATGGGCGGCACCGTCCTGGAGGCGCTCACCGCAGGCCGGCCGGTGGTCGTCACCGACGTGGGCGGGCTGCCCACCGTCGTCGGGCACGGCGCCGCCGGGCTCATCGTGCCGCCGTGCGACCCGCCCGCCCTTGCCGCGGCGATCCGCCAGTGCCTGGCCTCGCCGGAGCTGGCGGAGCGGCTCGGCCAGGCCGGGATGCAGCGCGCCGCGGGCTACGACCTGGAGAGCGTCACGCGGCGGCTGCTGGATGTCTACGCCGCCGTCGCCGGTGCGGCGGCGCAGGCCCAGCAGGCAACGCCGGCCGCCGGGGTGCGCGCCGGCTGA	MPSSDPAVMHVLRLTPYYYLAGRELTHRELQYEPIGGMQVQIMQTTEQLSELGIRQTVVFPQRPGMPRTVQLDARTSFELLSPPVAPIPTRSKGYVGLLVSWGLALVAWCVRQRLRGQHRQYSVIHMHCSELPWTFLFAVLARWLLRRPLALTVHCSALVTFHPETLAGRLLIGPARFFERVAIRRAEAVVVLTQRVRDAYVGLGLTDAERVHVVPDGVRLADFRPDRAAPAGTAEAESEPIVLYCGRFAPEKGWADYVDAAGLLVAEGTDARFVMCGDGNELARCRVQLRRLGIEDRVELLGHLDRPDIARTMRRAAVVVIPSRHEEMGGTVLEALTAGRPVVVTDVGGLPTVVGHGAAGLIVPPCDPPALAAAIRQCLASPELAERLGQAGMQRAAGYDLESVTRRLLDVYAAVAGAAAQAQQATPAAGVRAG	MKVMQLLPELNSGGVERGTLEIARALVAQGHQSLVVSNGGRLVSQLEAEGSTHLTLPIHKKSLSSLWQIRPLRQLIEEHQPDIVHVRSRVPAWLTHFALRKIPANKRPHLISTVHGFYSVNRYSAIMTQAEKVIAVSDSVVKYITGHYKNCPPQDIIRIYRGIDPAAFPHNYQPSAQWFNQVFNDFPELENKFLLCLPGRITRLKGHESLIELMQQLHSQYPQLHAVVVGGADVKKQAYLSELQNTIQSKGLADKITFVGHRSDIREWLAFSDIVLSLSNQAETFGRTALEALSVGTPVIGWNRGGVAEILSHVYPQGLVEAENEKALLEIVKHHIEQPQTVAPVTMFSLKDMCDQTLELYQSVLK	118.85	gnl|BL_ORD_ID|2840|hsp_num:0	3793		
BGC0000695.1|Fortimicin_12 # 15533 # 16804 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.715	BGC0000695.1|Fortimicin_12 	15533	16804	-	Loose	1400	26.5646	Ureaplasma urealyticum parC conferring resistance to fluoroquinolones	23.53	3003309	protein variant model	S84P	n/a	fluoroquinolone antibiotic	antibiotic target alteration	fluoroquinolone resistant parC	ATGAGCGCACTCGCTCTCGCCGGGGGCACCCCGGTACGCCAGGACCGGTCGTGGCCGGCGTGGCCGCAGTACGACCAGGCGACCGAGCAGGAGCTGATCGCCGCCCTGCGCTCCCGCCGCTGGGCGATCAGCTGGCCCAGCGACGGCACCCAGGCACGGGAGCGGCGTTTCGCCGACAAGTTCGCCCGCTACAACGGCGTGCCGTACTGCGTCAGCGTCGACCACGGATCGAGCGCCCTGCTCGTCGCGCTGGAGGCACTGAACATCGGTCCCGGCGACGAGGTCATCGTGCCGGACATGACGTGGGTCGCGCCGGTCACTGCGGTGCTGCGCGTCGGCGCGCTGCCGGTGCTGGTCGACTCCGACCCGCGCACTGGCTGCATCACCCCGGACACCATCCGTGCCGGGATGAGTGACCGCACGCGCGCCGTCATCGTGGTGCACCTGGCGTGCACGGTCGCGGACCTCGACGGCATCACCGCGCTCACCACGGAGGCGGGCATCCCGCTGATCGAGGACTGCGCGCAGGCACACGGCGCCCGGTGGCGCGGCCGTGCCGTGGGCACCCACGGCACGGTGGGCGTATTCAGTTTCCAGAACGGCAAGGTGCTCACCGGCGGTGAGGGTGGCGCGGTCATCACGGCCGACGAGGGCATCTACCGGCGGGTCCAGCAGCTCCGTGCGGACTCGCGCTGCTACCCCGAGGGTGGCCCGGTCGCCGGCCGGATGGAACTGATCGAGGCCGGCGAGATCATGGGCACGAACTACTGCATGTCGGAGCTGTCCGCGGCGATCCTGCTCGATCAGTTGCCCCGGCTCGACGCGCAGCACCAGCATCGGGAGAAGGTCGCGGGCGAGTTGGAGCGGGGCCTGGCCGAGCTGGGCGGGTTCGCGCCGGTACCGCTGCCGGAGCAGGCCGACGCCCGGTCGATCTACGAATACGGCATCCAGGTGGAGCCGGGCACCTTCGGCGCGGCCCCGCTGAGCCGGGTGGCCGAGGCGCTCACCGCCGAGCTGGGCATGACGTGGTACCCGGCCGACGCACCGCTGCACCGCAGCATCATGCTGCGACCGCAAACCAAACGGCGCTTCGCCACGCTGTGGGACGATCACGGCCGGGAACGGGCCCTCGGCCGGGACTTCAGCGGCGCCGAACGGTACTGCGACACGACCCTGCTGTTCCACCACTCGCTGCTGCTCGGTGACTCCGCCGACGTCAACGACATCGTCCGGGCGCTGGAGAAGGTGCGCGCGCACCATGCCGAGCTCTGA	MSALALAGGTPVRQDRSWPAWPQYDQATEQELIAALRSRRWAISWPSDGTQARERRFADKFARYNGVPYCVSVDHGSSALLVALEALNIGPGDEVIVPDMTWVAPVTAVLRVGALPVLVDSDPRTGCITPDTIRAGMSDRTRAVIVVHLACTVADLDGITALTTEAGIPLIEDCAQAHGARWRGRAVGTHGTVGVFSFQNGKVLTGGEGGAVITADEGIYRRVQQLRADSRCYPEGGPVAGRMELIEAGEIMGTNYCMSELSAAILLDQLPRLDAQHQHREKVAGELERGLAELGGFAPVPLPEQADARSIYEYGIQVEPGTFGAAPLSRVAEALTAELGMTWYPADAPLHRSIMLRPQTKRRFATLWDDHGRERALGRDFSGAERYCDTTLLFHHSLLLGDSADVNDIVRALEKVRAHHAEL	MSVNHQKIINTPLDNIVGESYAKYAKYIIQDRALPDIRDGLKPVQRRILYAMSELGIFYDKPYKKSARTVGEVIGKYHPHGDSSIYEAMVRMSQDWKNNLCLLDMHGNKGSIDGDNAAAMRYTEARLSKIASVMLANLKKDVVKFSPNFDDSEKEPSILPSLFPNLLINGATGIASGYATNIPPHNPNEVFDALIYRIDHPDCSVEKLIEICPAPDFPTGGEIHDLNGCANAHKTGEGKFIIRACIDFKINDNKINQIIISSIPYETNKALIIKEIEDIIYNKEVAGLIEVRDESDAKGISIIIDTKKDINLENVKNYLYKKTNLEISYNTKFIAIVHRTPTLVNLSTYLDAQINHSLDVINKVDLYDLNKILLRIEIVEGLIKCVDLIDEIIKIIRASESRQDAKNTLIQVFNFTNNQAEAIIMMRLHNLTRTDIFDLKNEWQTLQDEAKTLQERINSLQVRKNYLKQKMIEFKKTFGFERKTKLFDELVKVEINEDQMIEKQNLNLVISRDGYIKTVSKKSFESSKYDELGLKTNDILFYHNIINSHDKILIITSKAKLINLVAHKITSMRWKDVGEHLNNYVKFDANEKVIAVYIWNEQFKIDEYQLVLASRLNLIKRIELSELDINKNSKQISIMKLNDNDNLISANLIKKGHNQFIIAISKLGLALLFLVHEINCLNRLAKGIKIMKLKPNDEVSAILITPNNGYNVQLFLERGSKCFNISELKLSKRAATPTNLYPITKKVQNVLAAFLVAHENVFYLLDQQQKINPYYLSNPKPTKLDTKISIYENDQMITDVVKDCFLSDEAISDFKKINMYANEFDNEMLKINKNHDDSQLELIDEEEEKK	49.76	gnl|BL_ORD_ID|2421|hsp_num:0	2104		
BGC0000695.1|Fortimicin_13 # 16801 # 17862 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.750	BGC0000695.1|Fortimicin_13 	16801	17862	-	Loose	600	26.9498	vanHB	46.15	3002943	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanH; glycopeptide resistance gene cluster	ATGAACGAGCAGGACATGCTCGCTCTCGTGGTGCGGGGGCCCAAGGAGCACGCCGTCGAGCGCGTGTCCCGTCCGGTCCCCGCCCCCGGCGAAGCGCTGGTGGCGGTCACGGACGTGGCGATGTGCGGCACCGACCTGCGGCTGCTGCGCGGGACGCTGCACGACGCGGAGTACCCGGTGATCCCCGGGCACGAGTGGGCCGGTCGAGTTGTCGCGGCGCCGACCCGGCCGGAGCTGGTGGGCCGGGCGGTCGTGGCGGACAACATCCTGCCGTGCCGGGCCTGCCCGCAGTGCGCGGCGGGCCGGTTCAACCTCTGCACGGCCTGCGACGAGCTGGGCTTCACCCGGCCGGGGGCGTTCGCGCAGCTGCTCGCCATCCCGGCGGAGCAGCTCGAGCCGCTTCCGGAGCAGTTGTCCGGCGCGGAGGGCTGCCTCCTGGAGCCGCTGGGCGTGGCGCTGCACGCCTGCGAGCGCGGCCCCGACGTGCGGGGCCGGCTGGTGGGGGTCGTCGGCGGCGGAACGATCGGGCTGCTCGTGGCGCAGCTGGCCGCGTCGGCCGGGGCGGCGCGGGTGAGCGTCGTCGACCCGGTGGCGGCCCGGCGACAGCTGGCCACCACGCTCGGGCTGGACGCGCGGGCGGCCCTGAGCGACTGGGACGATGAGCAGCCCGAGGTCGTGTTCGACAGCACCGGCGTGGCCGACGTCTTCCCGGCCGGGCTGCGGGCCACCCGCCCGGGCGGCGCCTACGTGCTGGTCGGCTACTCGGGTGAGGAGGCAACCCGCTTCGAGCCCAGCACGGTCATGCTGCGCGAGCTCACGGTGTACGGCGTGCTGTCCGGCCAGGGACAGTTACGCCGCGCGCTGGCCGCGGCCACGTCGGGCGCGGTGCGGCTGGCGCCGCTGGTGAGCGAGCCGCTGCCGCTGAGCCAGTACCGGGCGGTCCTCGACGACACCGGCGAGGACGCACCGCTGCGTCGGTTCTTCGTGCTTGACCCGATCACCGAGGAGACCTCGGGCATCACCAACGCCCCGCCAGTACCGCAGGAAGGTGGACGTTCATGA	MNEQDMLALVVRGPKEHAVERVSRPVPAPGEALVAVTDVAMCGTDLRLLRGTLHDAEYPVIPGHEWAGRVVAAPTRPELVGRAVVADNILPCRACPQCAAGRFNLCTACDELGFTRPGAFAQLLAIPAEQLEPLPEQLSGAEGCLLEPLGVALHACERGPDVRGRLVGVVGGGTIGLLVAQLAASAGAARVSVVDPVAARRQLATTLGLDARAALSDWDDEQPEVVFDSTGVADVFPAGLRATRPGGAYVLVGYSGEEATRFEPSTVMLRELTVYGVLSGQGQLRRALAAATSGAVRLAPLVSEPLPLSQYRAVLDDTGEDAPLRRFFVLDPITEETSGITNAPPVPQEGGRS	MRKSMGITVFGCEQDEANAFRTLSPDFHIIPTLISDAISADNAKLAAGNQCISVGHKSEVSEATILALRKVGVKYISTRSIGCNHIDTTAAERMGISVGTVAYSPDSVADYALMLMLMAIRGAKSTIHAVAQQNFRLDCVRGKELRDMTVGVIGTGHIGQAVVKRLRGFGCRVLAYDNSRKIEADYVQLDELLKNSDIVTLHVPLCADTRHLIGQSEIGEMKQGAFLINTGRGALVDTGSLVEALGSGKLGGAALDVLEGEDQFVYTDCSQKVLDHPFLSQLLRMPNVIITPHTAYYTERVLRDTTEKTIRNCLNFERSLQHE	109.29	gnl|BL_ORD_ID|586|hsp_num:0	626		
BGC0000695.1|Fortimicin_14 # 17859 # 18593 # -1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.667	BGC0000695.1|Fortimicin_14 	17859	18593	-	Loose	500	28.1054	AIM-1	37.5	3000853	protein homolog model	n/a	n/a	cephalosporin; cephamycin; penam	antibiotic inactivation	AIM beta-lactamase	GTGACCAACGCCACGTATCTCGATCAGCGGCGGGCCGCAAAGGTCTACGGCGACGCTTTCCGCACCGTATTCGAGTACGTCTACGGCTGCCACATCCCCGGCAGCGTCGCCGAGTTCGGCTGCTTCGAGGGGTTCAGTTCGCTGCTGCTGGCGGACCTGATCGTCGAGTTCGACGCGGAGACCGACTTCTACGCCACGCTGCACCCACGCCACCTCTACGTCTACGACTCCTTCGCCGGGTTCCCCAAGAGCACCAACAACGTCGACTCGATCTCCTACGAGGTGGTCGACACGGGGTACTGGCGGGAGAGCGAGGATGCCTCCCCGCCGGGCACGGAGGAGATGCTGCGGCGGGAGTTCACCCGCCGCTTCGGCGACAGCGGCTGGACCATCGTGCGAGGCATGTACGAGCAGTCGCTGGTGTCCGACCCGCTGCAGCGGGAGGTCGCCATCGCCAACCTCGACTGCGACCTGTACGTCTCGAGCGTCCAGGTGCTCGACCACCTGCTGGGCAACCGGCTGCTGCCCGACGGTGCCGTCCTCCTGCTCGACGACTACAACTGCAACCGGGCGAACCCGCGTTTCGGGATGCGACGGGCGATGCGGGAGTGCTTCGCCCGCACCGACGGGTTCTACGACTACAGCGAGTTCCTGAGTTACGGCTGGCACGGCCGCGCGTTCTTCGTGCACCGGCTCGGCGACAGCCCGAACCCGGACGCCGAGGTGGGCGCATGA	MTNATYLDQRRAAKVYGDAFRTVFEYVYGCHIPGSVAEFGCFEGFSSLLLADLIVEFDAETDFYATLHPRHLYVYDSFAGFPKSTNNVDSISYEVVDTGYWRESEDASPPGTEEMLRREFTRRFGDSGWTIVRGMYEQSLVSDPLQREVAIANLDCDLYVSSVQVLDHLLGNRLLPDGAVLLLDDYNCNRANPRFGMRRAMRECFARTDGFYDYSEFLSYGWHGRAFFVHRLGDSPNPDAEVGA	MKRRFTLLGSVVALALSSTALASDAPASRGCADDAGWNDPAMPLKVYGNTWYVGTCGISALLVTSDAGHILVDAATPQAGPQILANIRALGFRPEDVRAIVFSHEHFDHAGSLAELQKATGAPVYARAPAIDTLKRGLPDRTDPQFEVAEPVAPVANIVTLADDGVVSVGPLALTAVASPGHTPGGTSWTWRSCEGDDCRQMVYADSLTAISDDVFRYSDDAAHPGYLAAFRNTLARVAALDCDILVTPHPSASGLWNRIGPRAAAPLMDTTACRRYAQGARQRLEKRLAEEAATSPSSGARP	80.53	gnl|BL_ORD_ID|665|hsp_num:0	707		
BGC0000695.1|Fortimicin_15 # 18619 # 19758 # -1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=9bp;gc_cont=0.671	BGC0000695.1|Fortimicin_15 	18619	19758	-	Loose	1200	24.6386	tetT	32.26	3000193	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic target protection	tetracycline-resistant ribosomal protection protein	ATGGTGACACAGTCACTACCGGTCATTCCGCTGACGATCCCGACGGTGCCGCGCCATGTCACGGCGTTCGTGAACTGGGCGTGCAACCTGACCTGCCGGGAATGCTGGATGTACGGCGACTCGGCGGCGGAGAGCACCTGGCTCCCCGAGGTCAAGCGCGACCAGATGAGCATCGAGATGTGGACGGCGCTGGTCGACGAGTTGGCCGCCGGCAACCGGGAGAAGGTGTACCTGACGATCATGGGCGGCGAGCCGCTCATGCATCGCGACGTCGTCGAGCTCATCCGCATCGCGAAGACCCGGATGCCGAACAGCAACCTCGACATGAGCACCAACGCCACGTTGCTGCCCCGCTTCGCGGACGACATCGTGGCCGCAGGCATCGACGACGTGTACATCTCGATCGACGGGCCCAGCCCGGAGGTGAACGACCCGATCCGCGGGCGCGACGCGTTCGAGCGGGCCGTCGCCGGGCTGCGCTCGCTGCAGGACGCCAAGGCACGGGCCGGCCACGGCCCGAACATCGCCCTGAACTTCGTGGTCACCGGCATGAACTACACGCACCTGGTCGACATGGTGCGCCTGTGCGAGCAGCTCGGCGTGGAGGAGATCACGGTCGGGCTGTCGAGCTTCTTCACCCGCGAGGAGGGCCACGCGTCGCGGGCCGCTTTCGAGGCGGTGACCGGCCGACCCTTCCTGTCCTGGGCCGGCTACTGCAACGAGCACCAGCACGCCGACCTCGTCCCGGAGCGGCTGGAGGAGCTGCTCGACGAGGCCGATCGGCTCAGCAACGGGGTCCGCGTGCTGGTGGCCCCGACCCGCTACACCAACCGCGAGAAGAGCCGGTTCTTCGCGAAGGACTGGCGCCGGATCGTGCGGGAGACAACCTGCGTCAAGCTGTGGGCGCAGACCACGGTGCTGCCCAATGGGCAGATCATCAGCTGCACCACGTTCGCCGACACGGTCATGGGCTCCATCCGCGACCAGTCCCTGAGCGAGGTGTTCCACGGCGACAGCTACACCCGGATGCGCGAGATGATCCGCGAAGGCCTGCAGCCCATCTGCCACCGCTGCTGCGAGCTCAACATGGACATCGACGTCGATCCTGCCCTCTACGACTCCGCCACTGTGAAGGGGTGA	MVTQSLPVIPLTIPTVPRHVTAFVNWACNLTCRECWMYGDSAAESTWLPEVKRDQMSIEMWTALVDELAAGNREKVYLTIMGGEPLMHRDVVELIRIAKTRMPNSNLDMSTNATLLPRFADDIVAAGIDDVYISIDGPSPEVNDPIRGRDAFERAVAGLRSLQDAKARAGHGPNIALNFVVTGMNYTHLVDMVRLCEQLGVEEITVGLSSFFTREEGHASRAAFEAVTGRPFLSWAGYCNEHQHADLVPERLEELLDEADRLSNGVRVLVAPTRYTNREKSRFFAKDWRRIVRETTCVKLWAQTTVLPNGQIISCTTFADTVMGSIRDQSLSEVFHGDSYTRMREMIREGLQPICHRCCELNMDIDVDPALYDSATVKG	MKIINIGILAHVDAGKTTVTEGLLYKSGAINKIGRVDNATTTTDSMELERDRGITIRASTVSFNYNDTKVNIIDTPGHMDFIAEVERTLKVLDGAILVISAKEGIQVQTKVIFNTLVKLNIPTLIFVNKIDRKGVCLDEIYTQIQEKLTSNLAIMQSVKIKDKGDFELTNVRDDKVIQSQIIEKLLDINDYLAEKYINGDVIAEKEYNDVFLDEINNCNLYPVFHGSALKNIGIDELLFAITKYLPTKSYNTEDLLSAYVYKIDRDEKSRKMTFLRVFSGNIRTRQDVYINGTEETFKIKSLESIMNGEIVKVGQVNSGDIAIISNANSLKIGDYIGKKYDGILDIKIAQPALRASIKPCDLSKRSKLIEALFELTEEDPFLDCEINGDTGEIILRLFGNIQMEVIESLLKSRYKIDARFGELKTIYKERPKRNSKAVIHIEVPPNPYWASIGLSIEPLPIGSGLLYKTEVSYGYLNNSFQNAVKDAVEKACKEGLYGWEVTDLKVTFDYGLYYSPVSTPSDFRNLTPYVFWEALRKAGTEILEPYLKYTVQVPNDFCGRVMSDLRKMRASIEDIIAKGEETTLSGKIPVDTSKSYQSELLSYSNGKGIFITEPYGYDIYNDKPIINDIGNDNNDSNKEGLRYLFQKQDEN	58.22	gnl|BL_ORD_ID|1921|hsp_num:0	2037		
BGC0000695.1|Fortimicin_16 # 19752 # 20660 # -1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.754	BGC0000695.1|Fortimicin_16 	19752	20660	-	Loose	700	26.1794	gimA	24.64	3000463	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	gimA family macrolide glycosyltransferase	ATGAGCACAGCCCAATCCCTCGACCACCCGGTCCCCGGCGCCCTGCGGCTCCCCCGGCCGGCCAAGGTGCTGCTGGTGTCCCCGCACCCCGACGACATCGCGTGGTCGCTGGGCGGCACGGTGGCGCGCGTCGCGGCGGCCGGGGCGGCGATGTCGGCGCTGACGGTGTTCGGCCGCACCAGCTACGCACCCGGGTCGGCGGCCCACGGCACGAGCGCGGCCATCGCGGTACGCGCCCGGGAGGACGTCATGTGGGCCACCGCGACCGGCGTGCGCCTGCACCGCGGCGACCTGCCCGACGCGAGCCTGCGCGGCTACGACGACGACACCGAGATGGGAGCGCAGCCCGAGCCGGCGATCGTGTCGGAGGTGGCCGACCGACTCACCCCCGTGCTGCGCGCGGCCCGCCCGGACCTGCTGCTCGTGCCGCTGGCCGTACGCGGGCACGTCGACCACCTGGCCGCCCGATCGGCCGCCGAGTACGTGGCGGCGGCCGAGGCGCCGGACTGCGCGCTGCTCTACTACGAGGACCTGCCCTACGCCGCCGGCGTGGACCACTCGCACACCGAGCACCCGGTGCTGGTCGACGTCGCGGGTTACCACGCCCAGCGCGAAGCGGGTGTGCTCTGCTACCCCTCGCAGGAGCCACACCTCATCCTGCCGATCATCGCCGCACACACGTCCGTGACGGGCGGCGAACGGCTGTGGGGCGCCACCGCCTCGGCCGCTCAGCGCCTCGCCGAGCTTCTCGCCGCCGCACCGCAGTCCGACCAACAGCCCGACCAACGGCCCGCCGAGCGCGGCTCAGGGCACCGGCCGCGCCGCGCGCCGGTCGTCGTCCACGCCTCGGCGCCGGCGGACCAGACCGCAGATTCGCCGCTCCGCAGAATGGAGTCCCAACCATGGTGA	MSTAQSLDHPVPGALRLPRPAKVLLVSPHPDDIAWSLGGTVARVAAAGAAMSALTVFGRTSYAPGSAAHGTSAAIAVRAREDVMWATATGVRLHRGDLPDASLRGYDDDTEMGAQPEPAIVSEVADRLTPVLRAARPDLLLVPLAVRGHVDHLAARSAAEYVAAAEAPDCALLYYEDLPYAAGVDHSHTEHPVLVDVAGYHAQREAGVLCYPSQEPHLILPIIAAHTSVTGGERLWGATASAAQRLAELLAAAPQSDQQPDQRPAERGSGHRPRRAPVVVHASAPADQTADSPLRRMESQPW	MRRGDLHETYRLDYAPHMHDPAHIAMFSIAAHGHVNPSLEVIRELVARGHRVTYAIPPLFAEKVAETGAEPKLWNSTLPGPDADPDAWGTTPLDNVEPFLDDAIQALPQLIAAYEGDEPDLVLHDITSYPARVLAHRWGVPAVSLSPNLVAWEGYEEEVGRPTWEEPLKTERGRAYDARFRGWLKENGITEDPDPFVGRPDRSLVLIPKALQPHADRVDEKTHTFVGACQGDRAAEGDWRRPEGAEKVVLVSLGSSFTKRPAFYRACVEAFGALPGWHVVLQVGRHVDPAELGDVPENVEVRSWVPQLAILKQADLFVTHAGAGGSQEGLATATPIVAVPQAVDQFGNADMLQGLGVGRHLPTEEATAEALRAAGLALVEDPEVARRLKEIQAGMAREGGTRRAADLIEAELAAART	72.42	gnl|BL_ORD_ID|1973|hsp_num:0	1994		
BGC0000695.1|Fortimicin_17 # 20660 # 21415 # -1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.724	BGC0000695.1|Fortimicin_17 	20660	21415	-	Loose	500	204.527	APH(3')-Vc	48.59	3002651	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	APH(3')	GTGGCAAGCCGCTCGTACGGCACGGTGATCCACCGGGTCGACGGCCGGCGCCACGCGTTCTACGTCAAGACGACGCCGCCGCGGCGCGACAACGACCTGCGGTTCCACCCGGGCAGCGAAGCCGAGCGTCTGCAGTGGCTCGCTGCCCGGGGCTTCCCGGTCGCCGAGGTGGTCGACGTGGGCGGTGACGACGAGCTGATGTGGCTGGTCACCACGGCCGTCGAGGGCCGCTCGGCGGCTGGGCCGTGGGCGACGCACGAGCGGCCCGTGGTGCTCGACGTCGTCGCCGACGTGGTCCGCGCGCTGCACGAGCTGCCGTTGACCGACTGCCCCTTCGACCGGACGCTGGCGGTGACCTTGCCGCTGGCCCGGCTGGCGGCCGAGATGGGCTGGATAGATCTCGACGACCTCGACCCGCAGCACCGCGGGTGGTCGGCGCGGCAGTTGCTCGACGAGCTGACGGCCACGCCGCCTCCCGCGGTCGAGGACCTGGTCGTTTGCCACGGAGACCCGTGCCTGGACAACTTCCTCGTCGCGCCGGACACGCTCGCGCTCACCGGCATCCTCGACGTGGGCCGGCTCGGGGCGGCCGACCGCTGGAAGGACCTGGCCATCGCCGTGCGCGACGTGACCGAGCAGTGTGCTGACGAAGGGGACGAAGGGCAGGCCGCCGCCGCGCGGTTCCTGGCGCGGTACGGCGCCCGCCCCGACGCAGGAAAAGACCGTTTCTACCGCCTTCTGGACGAGTTCGTCTGA	MASRSYGTVIHRVDGRRHAFYVKTTPPRRDNDLRFHPGSEAERLQWLAARGFPVAEVVDVGGDDELMWLVTTAVEGRSAAGPWATHERPVVLDVVADVVRALHELPLTDCPFDRTLAVTLPLARLAAEMGWIDLDDLDPQHRGWSARQLLDELTATPPPAVEDLVVCHGDPCLDNFLVAPDTLALTGILDVGRLGAADRWKDLAIAVRDVTEQCADEGDEGQAAAARFLARYGARPDAGKDRFYRLLDEFV	MYAMLRRKYQHYEWTSVNEGDSGASVYRLAGQQPELYVKFAPREPENSAFDLAGEADRLTWLTRHGIPVPCIVECGGDDTSVFLVTEAVTGVSAAEEWPEHQRFAVVEAMADLARTLHELPVGGCPFDRSLAVTVAEARHNLREGLVDLDDLQEEHANWSGDQLLAELDRTRPEKEDLVLCHGDLCPNNVLLDPETCRVTGMIDVGRLGRADRHADLALAARELEIDEDPWFGPEYAQRFLERYGAHHVDENKMAFYQLLDEFF	95.08	gnl|BL_ORD_ID|646|hsp_num:0	687		
BGC0000695.1|Fortimicin_18 # 21486 # 22814 # -1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.699	BGC0000695.1|Fortimicin_18 	21486	22814	-	Loose	2200	27.7202	rpoB2	30.95	3000501	protein homolog model	n/a	n/a	rifamycin antibiotic	antibiotic target alteration; antibiotic target replacement	rifamycin-resistant beta-subunit of RNA polymerase (rpoB)	ATGAAAAACCTGGAGACCATCGACCGGGCGCGGCGGGTCACCGCGGCCGAGCAGTACGACATCGGCACCCGGTTTCCCTCAGTGTTCGTCAAGGCGCAGGGGTCCTGGATGGAGGACGTCGAGGGACGGCGCGTCCTCGACGTGACCGCCGCGAGCGGTGCGCTGCTGCTGGGCAACCGGCACCCGGCCGTGGTCGAGGCGATCACCCGGTACATCGCCGAGCACGGCACCGTGTTCGCCAGCACGCTGTCGCTCCCGCGCATCGAGCTGGCCGAGCGGCTTTGCGAGCGCTACCCGGCCGGCGAGAAGGCGGTGTTCAGCAAGAGCGGCTCGGAGGCCACGACCGCCGCGATCCGGATGGCGCGCGCCGCCAGCGGTCGGGACATCATCGTGACCTCCGGCTACCACGGCTGGCACGACTGGCACCTGTCCTACCTCAACATCGGGTACAACCCCGGGACGCGTATCGCCTGCTACGGCTACAACGAGACGGCGCTGCGCCGGATGCTGCACGAGTTCGCCGGCGAGATCGCCGCGGTGATCGTGACGCCCGAGCCGGCGTGGTTCGACGAGGCGTACTACCGCCGCGTGTCGCAGCTGTGCGCGGAGCACGGCGTATACTTCATCATCGACGAGGTCATCACGGCGTTCCGGTACGGCCATCGGGGGCTCAACGGCACCGGCGAGGTGCCAGCCGACGCCATCACGATGAGCAAGGGCCTGGGCAACGGCCACTCCATCTCAGCCGTCGTCGGGCGCCGCGAGATCCTCGACGCCTACGACAAGGCCGGTGTCGCCGGCACCTACACGCGGGAGGTGCCGCCGATGGCGGCCGCCCTGGCGGTGCTGGACGTCACCGAGGACGGCTCGGTGCACGAGCACACCCAGCGGATGGGTGCGACGCTGCGCGACGGGATGCGCGACATCCTGGCCGCCGTGGGAATCCCGGCGTTCGTCAACGGGCCGCCGATGATGTTCGACGTCGTCGTGCCGTCCGAGCAGCTGTCGTGGGACATCTACCGAGCCGCCTACGACCACGGCGCCTACTTCGAAGACAGCGGCACGCACATGGTGACGGCGGCGTTCGGCCAGGCCGAGGTCGACCACGCGCTGGAGGCGTTCGAGAAGGGTGCGCGCGAGATCGCCAGGATCACCTCGTTCGACTTCGACGCGCTGCCGGAGTCGCGGCTGCACCAGTTCGCCTCGGAGGCGTTCGGCGGGGCGCTGCACGACGACGAGGCCGTCCTGCGCCGTATCGACGACACCGTGCATGCCATCGCCAACCGCGACCCGGCGCTGGCCCGCCTCCTCGACCCGTCCTGCGGCTGA	MKNLETIDRARRVTAAEQYDIGTRFPSVFVKAQGSWMEDVEGRRVLDVTAASGALLLGNRHPAVVEAITRYIAEHGTVFASTLSLPRIELAERLCERYPAGEKAVFSKSGSEATTAAIRMARAASGRDIIVTSGYHGWHDWHLSYLNIGYNPGTRIACYGYNETALRRMLHEFAGEIAAVIVTPEPAWFDEAYYRRVSQLCAEHGVYFIIDEVITAFRYGHRGLNGTGEVPADAITMSKGLGNGHSISAVVGRREILDAYDKAGVAGTYTREVPPMAAALAVLDVTEDGSVHEHTQRMGATLRDGMRDILAAVGIPAFVNGPPMMFDVVVPSEQLSWDIYRAAYDHGAYFEDSGTHMVTAAFGQAEVDHALEAFEKGAREIARITSFDFDALPESRLHQFASEAFGGALHDDEAVLRRIDDTVHAIANRDPALARLLDPSCG	MLEGRIVTVSSRTESPLAAPGVPGAPRRLSFARIREPLAVPGLLDIQTESFGWLIGAPDWCARAAARGTEPVAGLAEVLAEISPIEDFAGTMSLTLSDPRFEEVKASVEECKDKDLTYAAPWFVTAEFVNNNTGEIKSQTVFMGDFPMMTAHGTFVVNGTERVVVSQLVRSPGVYFDHAIDKGSEKDVHSARVIPSRGAWLEFDVDKRDTLGVRIDRKRRQPVTVLLKALGWSAERIAERFGFAPLIMASLAKDNVAGTDDALLEIHRKLRPGEPPTKESAQNLLANLFFTEKRYDLARVGRYKIDKKLGLRAPGAPRVLTEDDIAATIEYLVRLHAGERTMIAPGGVEVPVEVDDIDHFGNRRVRTVGELIQNQIRVGLSRMERVVRERMTTQDVEAITPQSLMNIRPVVAAMKEFFGTSQLSQFMDQRNPLASLTNKRRLSALGPGGLSRERAGLEVRDVHYSHYGRMCPIETPEGPNIGLMGYLSVYARVNPFGFVETPYRRVVDGRVTDEVDYLTADEEDRHVVAQANEPLDAEGRFLAARIPVRRKNSEVELVDSAAVDYMDVSPRQMVSVATAMIPFLEHDDANRALMGANMQRQAVPLIRSEAPIVGTGMELRAAVDAGDVVVNEKAGVVEEVSADYVTVMADDGTRKSYRMRKFNRSNQGTCSNQRPIVDEGQRVEAGQVLADGPCTENGEMALGKNLLVAIMPWEGHNYEDAIILSQRLVEQDVLTSIHIEEHEIDARDTKLGAEEITRDIPNVSDEVLADLDERGIVRIGAEVRDGDILVGKVTPKGETELTPEERLLRAIFGEKAREVRDTSLKVPHGESGKVIGIRVFSREDDDDLPPGVNELVRVYVAQKRKIQDGDKLAGRHGNKGVIGKILPTEDMPFLPDGTPVDIILNTHGVPRRMNIGQILETHLGWIGKAGWKVEGNPEWAKDLPEEMWEAPADSNIATPVFDGAREEELTGLLGSTLPNRDGERMVDDNGKAVLFDGRSGEPFPYPVAVGYMYILKLHHLVDDKIHARSTGPYSMITQQPLGGKAQFGGQRFGEMECWAMQAYGAAYTLQELLTIKSDDVVGRVKVYEAIVKGDNIPEPGVPESFKVLLKELQALCLNVEVLSAGAAVELAHGVDDDHERTAANLGINLSRAESITETELSG	38.04	gnl|BL_ORD_ID|2485|hsp_num:0	2831		
BGC0000695.1|Fortimicin_19 # 22811 # 22987 # -1 # ID=1_19;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.672	BGC0000695.1|Fortimicin_19 	22811	22987	-	Loose	800	22.3274	msrA	32.14	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGAGCCTCTACACCGGCGTGGCGTACCGCTCCGACCAGCTACCGCGCAGCCTCGGGGACGGGTGCGCCTTCGCCCTCGACAACGCCAACGTGGACAGCGACTTCGGCGGCGTCCACAAGACCGTCCTCGACGAGCTGGACGACGCCATGATGACGACCGAGACGGAGAACGTATGA	MSLYTGVAYRSDQLPRSLGDGCAFALDNANVDSDFGGVHKTVLDELDDAMMTTETENV	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	11.89	gnl|BL_ORD_ID|1132|hsp_num:0	1200		
BGC0000695.1|Fortimicin_20 # 23004 # 24641 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.686	BGC0000695.1|Fortimicin_20 	23004	24641	-	Loose	400	26.5646	vanRB	39.02	3002921	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	GTGACACGAGTGCTGCTGATCAAGCCGCCCATTCGCGCGTGCATGATCGAGATCGGCCGGCACATGCCGATCGGGCTCGCCTACCTCGCCGCCCAGCTGCGCAACAGCGGCATGGAAGTCGACATCTTCGATTCCCTGGCGTTCAGCGAAGACAACCATGTCGTGCCACCGTCGCAGTACACGGACATCGACCGGGCGAAGGTGGCGGCGCACCCGCGCTGGGACCACCTGGTGCACTGGGGCGCCGACTGGGCGCGTGTCGAGCAGGTGCTGCGGCGCGGTTATGACGTGGTGGGCGTGTCATGCATGTTCACGCCCTACTACGAGCCGGCGTACGAGCTGGGCCGGCTGGCCAAGCAGATCCTGCCGCAGGCGCGGGTGATCCTCGGCGGGCAGCACCCGACGGTGGCGCATCCGCACGCGCTGGCCGAGGAGGCGTTCGACGCGCTGGTGCTCGGTGAGGCCGAGGCCAACGTGGTAGAGATCGTCGAGGCGCTCGCCGCCGGGCGCAGCCTGCGCGGCATGCCGGGTCTCACGTTCCGCTGCGGCACCGGGCTCTGCGACTGCCCGCGCCCGTCGGGGGTGCACCTGCAGCCGCGAGCCGAGTTCCTCCAGGACCTCGACGGCCTGGCGCTGCCCGCCGTCGACCTGCTCGACATGGGGAGCTACGACGAGACCGCCACGCTGATCACGAGCCGTGGTTGTCCGTTCTCCTGTTCGTTCTGCACGGTGCACGCCACCGTCGGCAAGAAGTTCCGCGCCCGCGCACCGGAGAACGTGGTCGACGAGATCGAGCACTACGTGACCGAGCACGGTATCCGGCGGTTTTTCATCGAGGACGACAACTTCACCTTCGACATCGCCCGCGTGCACGAGATCTGCCGGGCCATCACGCGTCGCGGCCTCGACGTGGAGCTGCACCTGCCCAATGGCATGACAGTGGTGAAGCTGGACAAACCGCTCGTCGACGACATGGCCGCCGCCGGCTTCCAGAGCCTGTTCCTGGGCTTGGAGACGACCGACGTCAAGCGGCTACGCCAGATCCGCAAGGGCTTCACCTCACTGGAGAAGGTCAACGCGGGGGCCGGCCTGTTCACCGACCACGGCATCACCGTCGGGGCATCGCTCATCGTGGGGCTGCTCGGGCAGACCCCGGCCGAGGTCGCCCGCGACTCGATCAACTTGATGCTCGCCGGCATCCGGTTCTGGACCAACCCGTTCTACCCGATCCCGGGCTCGCCGGACTTCCAGCAGTGCCTCGCCAACGGGCTCATCACGCACGACACCGAGCTGGCGCTCTACGACCAGTTCAACTTCGCGATCGGCTCCGACCACCTGTCCCCGGCGGAGCTGTACTGGTCCGTCGTCATCACGCAGGCCATGGCGCACTGGCCGGACTACGTGCTGGAAGGCGCGCGAGTCCGGCGTGAGCGCGGGACGGTCGGCCTCGACGAGGCGCTGCAGCGGCTGCTCGCCCACAGCGACAGCCTGTTCGGCCCGAACGGTGAGCTGGAGGTGCCGGCGGTGCCGGGTCGATCGACGGCAACGTCGTGCACGGCCACCCGGAGGCTGCTTCCACGCGGCGCAGCGCATCAGCCCGCAGCGACTGCCCGGCGAGGTCTGCACCTTCACCGGTGA	MTRVLLIKPPIRACMIEIGRHMPIGLAYLAAQLRNSGMEVDIFDSLAFSEDNHVVPPSQYTDIDRAKVAAHPRWDHLVHWGADWARVEQVLRRGYDVVGVSCMFTPYYEPAYELGRLAKQILPQARVILGGQHPTVAHPHALAEEAFDALVLGEAEANVVEIVEALAAGRSLRGMPGLTFRCGTGLCDCPRPSGVHLQPRAEFLQDLDGLALPAVDLLDMGSYDETATLITSRGCPFSCSFCTVHATVGKKFRARAPENVVDEIEHYVTEHGIRRFFIEDDNFTFDIARVHEICRAITRRGLDVELHLPNGMTVVKLDKPLVDDMAAAGFQSLFLGLETTDVKRLRQIRKGFTSLEKVNAGAGLFTDHGITVGASLIVGLLGQTPAEVARDSINLMLAGIRFWTNPFYPIPGSPDFQQCLANGLITHDTELALYDQFNFAIGSDHLSPAELYWSVVITQAMAHWPDYVLEGARVRRERGTVGLDEALQRLLAHSDSLFGPNGELEVPAVPGRSTATSCTATRRLLPRGAAHQPAATARRGLHLHR	MSIRILLVEDDDHICNTVRAFLAEARYEVDACTDGNEAHTKFYENTYQLVILDIMLPGMNGHELLREFRAQNDTPILMMTALSDDENQIRAFDAEADDYVTKPFKMRILLKRVEALLRRSGALAKEFRVGRLTLLPEDFRVLCDGTELPLTRKEFEILLLLVQNKGRTLTHEIILSRIWGYDFDGDGSTVHTHIKNLRAKLPENIIKTIRGVGYRLEESL	247.73	gnl|BL_ORD_ID|126|hsp_num:0	141		
BGC0000695.1|Fortimicin_21 # 24691 # 26151 # -1 # ID=1_21;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000695.1|Fortimicin_21 	24691	26151	-	Loose	600	26.1794	CfxA6	29.17	3003097	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGGTAATTGACGTGGTTGATGCTGCCCCAAATTACGACGTGGTCGTCGCCGGTAACGGCGCACTCGGGTTGTCGCTCGGACTGGTCCTGGCGCGGCGGGGCCTGCGGGTGGCGGTGGTCGGCCGGGCCGACCGGACCTACGCCGCCTCCGCCGCCGCCGGTGCCATGAACGGGTGCTTCGGCGAGGTCACCCCGCACCTGCTGCGCAGCGAGCACGGCCGGTTGAAGCTGGCCATGGACTACCAGGCGACCGGCCGGTGGGACGCCTGGGAGCAGGGTCTGCTGGAGGAGTCCGACGAGACCGCGATCCGCACGGCGAACGGCACCGTGGTCATCCTGAACACCGTCGGCGTCCACGAGATCGACACGGAGGGCTTCCGGGCCATCCGCGCGGCGCTCGACGAGTACAAGGAGCCCTACGAGGACCTCGACCCGGCCGAGGTGCCGTGGCTGCACCCGGCGCCGACCGCCCGGCCGCTGCACGCGATGTTCATCCCGGGCGAGCACGCGGTCGACGCCCCGGCGCTGCTCCGGGCGCTCTCCGCGGCGTTCACCCGCAACGGCGGCACGCTCGTCGACGACCTCGTCGGCGAGGTGCTGCTGGTCGGTGGTCGTGCCGTCGGCGTACGGCTCACCAGCGGTACGACCCTGTCCGCCGGCCACGTCGCCCTGGCGACCGGCGCGGCCACCACGAAGCTGCTGGACTGCCTGCCCGAGGACGTCCGCCACCGGATCCCCGCCATCGTCGCTGGCCGCGGGGTGGCCCTCATGGTGCGCACGACGGACGGCGTCGTTCCGGAGTCGGTGATCCGCACCCCCAACCGGGCGTTCGCCTGCGGGCTGCACGTGGTGCCGCGCCGCGACGGGCTGATCTACCTGGGCGCCACCAACGAGGTGGAGTCGCAGCTCGGTACGACGGCCGCGATCGGCGAGCTGAACCTGCTGCTCAGCGGCACCAGCCAGATGCACGACGACCTGGTGAACGCCTGGGTGGAGCGGATCATGGTGGGCAACCGTCCGGTCCCGCTGGACGGCTTCCCGCTGCTGGGCTCGGTCGGAGTCGAGGGTCTGTGGCTCATGACCGGCACGTACCGCGACGGCTTGCACCAGTCGCCGCTGCTGGCCGCGGACATGGCGGCACGGATCCTCGGGGAACCGCACGACAGCGAGCTGGACGTCTTCACGCCGGTACGCCCGCCGATCGAGGCGATGACGCGCGAGGAGTCCCTCGAGATGGCCGTGCGGCACACCCTGGGCAGCGGTTACGAGCACGAGTGGCGGCTGCCGGACGACTGGCCGCCGATGATCGAGAAGCACTTCCGGGCCGCGTTCGGCCGAACGCTGGAACAGGTCGATCCGGAGTTCGTCCCGCCGCCGGAGATGTTCATCTTCGCCGACGAATCCATCCACGCCGCGCTGCGCACGTACTACGAGGCGCACCGGGGCGCGTCCGGACGGTAG	MVIDVVDAAPNYDVVVAGNGALGLSLGLVLARRGLRVAVVGRADRTYAASAAAGAMNGCFGEVTPHLLRSEHGRLKLAMDYQATGRWDAWEQGLLEESDETAIRTANGTVVILNTVGVHEIDTEGFRAIRAALDEYKEPYEDLDPAEVPWLHPAPTARPLHAMFIPGEHAVDAPALLRALSAAFTRNGGTLVDDLVGEVLLVGGRAVGVRLTSGTTLSAGHVALATGAATTKLLDCLPEDVRHRIPAIVAGRGVALMVRTTDGVVPESVIRTPNRAFACGLHVVPRRDGLIYLGATNEVESQLGTTAAIGELNLLLSGTSQMHDDLVNAWVERIMVGNRPVPLDGFPLLGSVGVEGLWLMTGTYRDGLHQSPLLAADMAARILGEPHDSELDVFTPVRPPIEAMTREESLEMAVRHTLGSGYEHEWRLPDDWPPMIEKHFRAAFGRTLEQVDPEFVPPPEMFIFADESIHAALRTYYEAHRGASGR	MSNYSVAELRNMKKNRKKQIVVLCIALVCIFILVFSLSHKSATKGSANPPLTDVLTDSISQIVSACPGEIGVAVIINNTDTVSVNNKSIYPMMSVFKVHQALALCNDFDKKGLSLDTLVKINREKLDPKTWSPMMKDYSAPVISLTVRDLLRYTLSQSDNNASNIMFKNMLNTAQTDSFIAKLIPRSSFQIAYTEEEMSADHDKAYSNYTSPLGAAMLMNRLFTESLISNEKQDFIKNALKECKTGIDRIVAPLLDKEGVVIAHKTGSGNVNENGILAAQNDVAYICLPNKVCYTLAVFVKDFKGNESQASQFVAHISAVVYSLLINTALN	146.83	gnl|BL_ORD_ID|248|hsp_num:0	268		
BGC0000695.1|Fortimicin_22 # 26820 # 27392 # 1 # ID=1_22;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.679	BGC0000695.1|Fortimicin_22 	26820	27392	+	Loose	650	25.0238	EreA	25.45	3000361	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide esterase	TTGCCGTGTTGTCTGACACGCAACGATGCGTCGCGCAATTTCTGTGTGGGCAGAGAAGATATTCGCAATACCGGCACGCCCTTTGGCGTGCAGACAGGAGTGACGATGGCCGCTGCCAACTCTTCCGGCGTCTCGAAATTCCGATTGCGAGTCGACCGTCTCGCGCCGCACATCATGCAGGCGATGGAGGCCCTCGACGGGGCCGCCGACAAGGTGAGCCTCGACCAGGGGCTGCTCGAGCTGGCCCGCACGCGGGCGTCGCAGCTCAACGGATGCGCGTTCTGCGTCAACGCGCACACGCAGGCCGCCAGCGAGCACGGCGCCACGCCGCAGCAGCTGGCGACGCTGATGACGTGGCGGGAGGCGCCGTTCTTCTCCGACCGCGAGCGCGCCGCGCTGCTGCTGACCGAGGCGGTGACCCTCGTGAACCAGGCGCCGGTCACCGACGAGCTGTGGGCCGAGGTCGGTGCCCACTTCACCGAGACCGAGCTGGCGGAGCTGCTGTGGTCGATCGCGGTCATCAACGTGTGGAACCGCATCGCCGGTACCGCCCACCCGTGGCCCGTGGCGTGA	MPCCLTRNDASRNFCVGREDIRNTGTPFGVQTGVTMAAANSSGVSKFRLRVDRLAPHIMQAMEALDGAADKVSLDQGLLELARTRASQLNGCAFCVNAHTQAASEHGATPQQLATLMTWREAPFFSDRERAALLLTEAVTLVNQAPVTDELWAEVGAHFTETELAELLWSIAVINVWNRIAGTAHPWPVA	MTWRTTRTLLQPQKLDFNEFEILTSVIEGARIVGIGEGAHFVAEFSLARASLIRYLVERHEFNAIGLECGAIQASRLSEWLNSTAGAHELERFSDTLTFSVYGSVLIWLKSYLRESGRKLQLVGIDLPNTLNPRDDLAQLAEIIQLIDHLMKPHVDMLTHLLASIDGQSAVISSAKWGELETARQEKAISGVTRLKLRLASLAPVLKKHVNSDLFRKASDRIESIEYTLETLRIMKTFFDGTSLEGDTSVRDSYMAGVVDGMVRANPDVKIILLAHNNHLQKTPVSFSGELTAVPMGQHLAERVNYRAIAFTHLGPTVPEMHFPSPKSPLGFSVVTTPADAIREDSMEQYVIDACGTENSCLTLTDAPMEAKRMRSQSASVETKLSEAFDAIVCVTSAGKDSLVAL	46.80	gnl|BL_ORD_ID|937|hsp_num:0	991		
BGC0000695.1|Fortimicin_23 # 27450 # 28511 # 1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.749	BGC0000695.1|Fortimicin_23 	27450	28511	+	Loose	1280	26.9498	macB	45.45	3000535	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	ATGCGGGTCGGTCTGATTGGTGCGGGGCGGATCGGCGCGGTGCACGCCCAGTCGCTGGCCGGCGACCCGCGCGTGCGCCGGGTCGACGTGGTCGACGCCGACCCGGATCGCGGACGGCGGGTGGCCGAGGCGGTCGGCGGCCACGTCGCGGACAGCGTCGATGCGCTGCTGGACGATGCACCGGACGCCGTGGTGGTCGCCACGCCGACGCACACGCACGCCGACCTGGTCGTACGCTTCGCCGCGCGGGGCATCCCCGTGCTGTGCGAGAAGCCCGTCTTCGCTGACCTGGCCACCGCCCGCCGGGTCGCCGCGCAGGTGCGCGAGATCGGCACGCCGGTGCAGGTCGCCTTCCAGCGCCGCTTCGACCCCGGCTACCTGCGCGGCTATGAGGCGGTGCGCTCCGGCGCCGTCGGACAGCTCCGGCGCATGCATCTGGTGACCGCCGACCCGGAGCCGCCGCCGGCGGCCTACGTGGCCGTCTCCGGGGGTATCCACCGGGACTGCCAGATCCACGACTTCGACGTGCTGCGCTGGATCAGCGGGCGCGAGGTGGTCGAGGTCTACGCGACCGGCGCCAACCGTGGCGCCGGCTACATCGGTGCCGCGGGGGACGCCGACGAGGCCGTGGCCGTGCTGACCCTCGACGACGGCACCCTGGCCACGATGCAGGCGTCGCGCTACAACGGGGCCGGCTACGACGTGCGGATGGAGCTGGCGGGCAGCAGTGCGACGCTGGCGGTCGGGCTCGACACCAGGGTGCCGCTGCGCTCCGTCGAGCCGGACGCGCCACCGTTCGCCGCGGCGGCCTGGTCGGGGTTCCTGGACCGCTTCGCGGCTGCCTACCGCGCGGAGGTGGCGGCCTTCCTCGGCCTGGTCGCGGCGTCGACGGCTGGATCGTCCACCGGGCTGTTCGGCCACTGTACCGTCGACGATGCGTTGCAGGCGCTGCTCATCGCCGAGGCGGCCGCCACGTCGCGCCGCGAGCGGCGTCCGGTACTCCTGGCCGAGGTCGGCAACGAGATAGCGCCGGTCGTGCCGGTGGGGACGGCGGCCGCGTGA	MRVGLIGAGRIGAVHAQSLAGDPRVRRVDVVDADPDRGRRVAEAVGGHVADSVDALLDDAPDAVVVATPTHTHADLVVRFAARGIPVLCEKPVFADLATARRVAAQVREIGTPVQVAFQRRFDPGYLRGYEAVRSGAVGQLRRMHLVTADPEPPPAAYVAVSGGIHRDCQIHDFDVLRWISGREVVEVYATGANRGAGYIGAAGDADEAVAVLTLDDGTLATMQASRYNGAGYDVRMELAGSSATLAVGLDTRVPLRSVEPDAPPFAAAAWSGFLDRFAAAYRAEVAAFLGLVAASTAGSSTGLFGHCTVDDALQALLIAEAAATSRRERRPVLLAEVGNEIAPVVPVGTAAA	MSLIECKNINRYFGSGENRVHILKDISLSIEKGDFVAIIGQSGSGKSTLMNILGCLDTAGSGSYRIDGIETAKMQPDELAALRRERFGFIFQRYNLLSSLTARDNVALPAVYMGMGGKERSARADKLLQDLGLASKEGNKPGELSGGQQQRVSIARALMNGGEIIFADEPTGALDTASGKNVMEIIRRLHEAGHTVIMVTHDPGIAANANRVIEIRDGEIISDTSKNPEIPASNVGRIQEKASWSFYYDQFVEAFRMSVQAVLAHKMRSLLTMLGIIIGIASVVSVVALGNGSQKKILEDISSMGTNTISIFPGRGFGDRRSGKIKTLTIDDAKIIAKQSYVASATPMTSSGGTLTYRNTDLTASLYGVGEQYFDVRGLKLETGRLFDENDVKEDAQVVVIDQNVKDKLFADSDPLGKTILFRKRPLTVIGVMKKDENAFGNSDVLMLWSPYTTVMHQITGESHTNSITVKIKDNANTRVAEKGLAELLKARHGTEDFFMNNSDSIRQMVESTTGTMKLLISSIALISLVVGGIGVMNIMLVSVTERTKEIGIRMAIGARRGNILQQFLIEAVLICIIGGLVGVGLSAAVSLVFNHFVTDFPMDISAASVIGAVACSTGIGIAFGFMPANKAAKLNPIDALAQD	54.81	gnl|BL_ORD_ID|459|hsp_num:0	487		
BGC0000695.1|Fortimicin_24 # 28508 # 29350 # 1 # ID=1_24;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.731	BGC0000695.1|Fortimicin_24 	28508	29350	+	Loose	700	24.6386	CMY-41	28.57	3002052	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CMY beta-lactamase	GTGAACGCGCCCGCCCCGGCGGCCGGGGCAGGCGCCACGGCGCTCACGGCGGCGACCGGTGGCCTTGCCCTGTCCGAGGACGCGGTCTTTGCCGACTTCGCCGCGCGGGTGCCGCTCGCTGGCGCCCACGTCGTGGAGATCGGCGGCTCGCTGTCCGAGAACCTCGCGGAGCTGCACGGTGTCGGCCGGTGGACGTCGGTCGATCCGAACCGGCCCGCCGGGGCCGGCCCGTCCGGCCGCACCGAGGTGGTACGGGCGCGGGCCGAGGACATGCCGCTGCCCGACGCGTCCGCCGACGCCGTGTTCTCCAGCAACGCCTTCCAGTTCATCGACGTCACCGCGACCCTGGCTCAGGTACGGCGGGTGCTGCGCCCCGGCGGCCTGCTCTACGCTCACTTCGGCCCGATCTGGAGCGCTGTCGACGGCCACCAGCTCGAATACGTCTCGTACGAGGGCCGCGACCTGCTCTTCTGGCAGGACACGCTGCTGCCTCCGTGGGCGCATCTGGCCTACGACCGGGCCGAGTTGCGGCAGCTGCTGGGCACCGCGCTGCCGGACGACCTCGCCGACCTGCTGGTGTGGCACGTGTACGACAGCGCCACGGTCAACCGGCTGTTCTTCGAGGACTACGTCGAGGCCGTCCTGCACAGCGGACTCGACCTGGTGGAGGCGCGGGCCTCGCACCATCTCGACTACGAGCTGCGGCTGCCCGCGTTCGATCCGCAGCACCTGCGCGAGGTGACCCCGGCCGAGCTGGCGGCCACCTGGACGGCCCGACGCGGCAGGCCCACCCGGGTCGGCGCCCGGGACGTCCTGCTGGTGCTCCGTCAGCCCATCGAATAG	MNAPAPAAGAGATALTAATGGLALSEDAVFADFAARVPLAGAHVVEIGGSLSENLAELHGVGRWTSVDPNRPAGAGPSGRTEVVRARAEDMPLPDASADAVFSSNAFQFIDVTATLAQVRRVLRPGGLLYAHFGPIWSAVDGHQLEYVSYEGRDLLFWQDTLLPPWAHLAYDRAELRQLLGTALPDDLADLLVWHVYDSATVNRLFFEDYVEAVLHSGLDLVEARASHHLDYELRLPAFDPQHLREVTPAELAATWTARRGRPTRVGARDVLLVLRQPIE	MMKKSICCALLLTASFSTFAATKTEQQIADIVNRTITPLMQEQAIPGMAVAIIYEEKPYYFTWGKADIANNHPVTQQTLFELGSVSKTFNGVLGGDAIARGEIKLSDPVTKYWPELTGKQWRGISLLHLATYTAGGLPLQIPDEVTDKAALLRFYQNWQPQWTPGAKRLYANSSIGLFGALAVKPSGMSYEEAMTRRVLQPLKLAHTWITVPQSEQKNYAWGYREGKPVHVSPGQLDAEAYGVKSSVIDMARWVQANMDASHVQEKTLQQGIELAQSRYWRIGDMYQGLGWEMLNWPLKADSIINGSDSKVALAALPAVEVNPPAPAVKASWVHKTGSTGGFGSYVAFVPEKNLGIVMLANKSYPNPARVEAAWRILEKLQ	73.49	gnl|BL_ORD_ID|1021|hsp_num:0	1086		
BGC0000695.1|Fortimicin_25 # 29359 # 30204 # 1 # ID=1_25;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.739	BGC0000695.1|Fortimicin_25 	29359	30204	+	Loose	700	25.0238	oleI	45.83	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	GTGACCACCGAGCAGATCCTGCCGTTACGGGAGTCCCGGGCACTGCCGCTGGACGGGTTTCTCCGCGCCGCGGTGCGGGCGGCCCGCGCCGCCGGCAGGGTCGTGCGGACCGCGTTTCACGAGGGCCGCACCGTCGTCGAGGACAAGGGTCCGCGCGACTACGTCACCGAGGTGGACCGGGCCGCCGAGGACCTCATCCACGACTACCTGCACCGGCACGCGCCTGAACAGGTGCCGTTCGTCGGCGAGGAGTCCGGTGGTGTGCTGGGAACGCTGTGCTGGGTGGTCGACCCGCTGGACGGTACGACCAACTTCCTGCGCGGCTATCCGTCGGTAGGGGTGTCGATCGCGCTCGTGCACGAGGGGCGGCCCGTCGTCGGCGTCGTGCACGCACCGATGTGGGGCGAGACCTTCACGGCTGTGGCCGGCGGCGGGGCCCTGCGCAACGGCCGGCCGATCGCGGTCGGCACCCGCCCGGCCGCGCGAGCGGTGTGTTCGACCGGTCTGCCGGTGAAGCGCCCCGAGGCGATGGGCGCCTACCTCGACCTGCTGGGCCGCCTGCTGCCGGCTGTCGAGGACGTGCGTCGGCCGGCCGGGGCCAGCCTTGACCTGGCGTGGGTGGCGTGCGGGGTGTTCGACGCCTTCTTCGAGCTCGACCTCGGCCCGTGGGACGTGGCCGCCGGGGCCCTGCTGGTCCGCGAGGCGGGCGGCGTGGTGACCGACTGGGAGGGTGACCCCGGCCGCTGGCTGGACACCGGGCACATCGTGGCCGGTTCGCCGAGTGTGCATGCGACGGTGGTGCGGCACACCAGCACGACCGCACTGCCGGTGCTCCGGCGCCCCTGA	MTTEQILPLRESRALPLDGFLRAAVRAARAAGRVVRTAFHEGRTVVEDKGPRDYVTEVDRAAEDLIHDYLHRHAPEQVPFVGEESGGVLGTLCWVVDPLDGTTNFLRGYPSVGVSIALVHEGRPVVGVVHAPMWGETFTAVAGGGALRNGRPIAVGTRPAARAVCSTGLPVKRPEAMGAYLDLLGRLLPAVEDVRRPAGASLDLAWVACGVFDAFFELDLGPWDVAAGALLVREAGGVVTDWEGDPGRWLDTGHIVAGSPSVHATVVRHTSTTALPVLRRP	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	66.27	gnl|BL_ORD_ID|1723|hsp_num:0	1824		
BGC0000695.1|Fortimicin_26 # 30277 # 30423 # -1 # ID=1_26;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.680	BGC0000695.1|Fortimicin_26 	30277	30423	-	Loose	400	20.4014	Erm(34)	29.55	3000600	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGTCCGGCAGCACCCACTGTTCCAGCCGTTGGACGAGGAGTCGTTCTCCAACATCTGCACGTTCTGCATGCGGGCCCTGAGCGATCCGGCCCGGGTGGCGGCGCTGGAGGAGCTGCTGCACGCAGCGCCGACCGCGGCATCCTGA	MVRQHPLFQPLDEESFSNICTFCMRALSDPARVAALEELLHAAPTAAS	MTKKMNKYNGKKLSRGEPPNFSGQHFMHNKRLLKEIVDKADVSVRDTVLELGAGKGALTTILSERADRVLAVEYDQKCIEALQWKLVGSKNVSILHQDIMKVALPTEPFVVVSNIPYSITTAIMKMLLNNPKNKLQRGAIVMEKGAAKRFTSVSPKDAYVMAWHMWFDIHYERGISRSSFSPPPKVDSALVRIVRKQHPLFPYKEAKAMHDFLSYALNNPRAPLDQVLRGIFTAPQAKKVRQAIGVKPETPVAMLHARQWAMVCDAMVRHVPKVYWPRRKR	17.08	gnl|BL_ORD_ID|7|hsp_num:0	11		
BGC0000695.1|Fortimicin_27 # 30466 # 30936 # -1 # ID=1_27;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=4bp;gc_cont=0.692	BGC0000695.1|Fortimicin_27 	30466	30936	-	Loose	700	25.0238	AQU-2	38.89	3004647	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	AQU beta-lactamase	TTGGCGCGGGAGAAGCTCACGCCATTTGTGGAGGCCGGCATCTCCGGTCTCGCTTTGAGCGCCGACATCTACCACATGAAGTACTTCCCGGTGGAGCGGCCGATCACCGCGGCCCGTACCGCGCGGTCGTTCGGACTGGCGACGGAGATTCAGTTCTGCCGCTCGCATCACCGCGAACGCGACGAGGAGATCATCGCCGCACTCGCCGCGGCCGGTGAGCCCTACGTGGTGCTCGAGCTGCTGGACCGGGGGCGCGCCCGGGAGATGCTGCAGGTGTGGCGCGGGCACCGGGTCGAGGAGCTGTCGGAGTGCGATGACCTCACCACCACGCTCCACGCCACCGGCGACGTCTACGCCTGCTGCCAGCTCGACATCGGGGTCGACCAGATGAAGCGCACGCCGGTCTTCCTCGGCTCGATCCGCTCCGCCGACTCGGACGCGGCGGCCCGCGACCGCCGGGAGCAGCTGTAG	MAREKLTPFVEAGISGLALSADIYHMKYFPVERPITAARTARSFGLATEIQFCRSHHRERDEEIIAALAAAGEPYVVLELLDRGRAREMLQVWRGHRVEELSECDDLTTTLHATGDVYACCQLDIGVDQMKRTPVFLGSIRSADSDAAARDRREQL	MKQTSPLSLLALSALLLSPLTQAAPADPLVGVVDDVIRPLVKEHRIPGMAVAVFKEGQPHYFNYGVAELATGKKVSEQTLFEIGSVSKTLTATLGAYAVVKGSIGLDDKVSRHAPWLKGSAFDGITMAELATYSAGGLPLQFPDEVESLEQMQAYYRQWTPAYQPGSHRQYSNPSIGLFGYLAASSLQQPFAQLMEQTLLPGLGLHHTYINVPKQAMANYAYGYSKEDKPIRVNPGMLADEAYGIKTSSADLLAFVQANINGVDDKGLQQAIALTHQGHYSVGGMTQGLGWESYPYPVSEQTLLAGNSAQVIMKANPTTAAPXEMGSQRLFNKTGSTNGFGAYVAFVPAKGVGIVMLANRNYPIQERVKAAHAILSKLAP	41.05	gnl|BL_ORD_ID|2182|hsp_num:0	3346		
BGC0000695.1|Fortimicin_28 # 31607 # 31906 # 1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.720	BGC0000695.1|Fortimicin_28 	31607	31906	+	Loose	500	43.5134	sgm	27.71	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	ATGCTGGTCACACGGGACCCGATCACCGCCGACGGGGCGCTGCTGCTCAAGACGTACCATTGCGTGGAGGACCGGCTGTCCGGCGCGGGGCTGCGCCTCGTCGCCGAGGTCGCGGCCAACAAGGTGGTGGTGTCGTTCCCGCTGCGCGTCATGAATGGCCGGGCCGCGGTGTTCACCCGCCCCCACAACGACGCGCTGTCGCGCCTCGCCGACGAGCGGGGGTGGGCGGTGCGCCGGGCCCGGCTGAGCACCGAGGAGTTCGTGGACGTCGACAAGGAGCGCGGTGGCACGGAGCACTGA	MLVTRDPITADGALLLKTYHCVEDRLSGAGLRLVAEVAANKVVVSFPLRVMNGRAAVFTRPHNDALSRLADERGWAVRRARLSTEEFVDVDKERGGTEH	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	36.13	gnl|BL_ORD_ID|1952|hsp_num:0	2079		
BGC0000695.1|Fortimicin_29 # 31890 # 32825 # 1 # ID=1_29;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=5bp;gc_cont=0.745	BGC0000695.1|Fortimicin_29 	31890	32825	+	Loose	450	105.531	armA	25.59	3000858	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GTGGCACGGAGCACTGAGACGCGGGTAGACCTGGCCGCTGAGGTGGCCCGACAGGTGCTCGCCGCGGCGAAGTACCGCAACCTGGACCCGGCGTTCGTCGAGCGCCTGGCGCAGGAGGCGGCGGAGCGATTCCGCGACCGCGGCCAAGCGGTCAAGTACGCCAAACGGAAGCTGCACCAGGCATTCGGCGCATTCGTCGCGGGCACGCCGGCGCAGGCGGTCGCCGCCTGCGTCGCGAAGATCGCCGCCGGAGCGGAGCCGAAGGAGGCGGGCCGGGAGGCGATGCGGGCACACGCCTCCTCGGCGGAACGGGTCGACTGGCTGGAGCCGTTCTACGAGCGCGTCGCCCAGTGGTGCGGCCCGGCATCCTCCGTGATCGACCTGGCCTGCGGCCTCAACCCGCTGGCCGTGCCGTGGATGGCGCTCGCTCCCGGCGCCACCTACGCCTGCTACGACGTGGACCGGACCATGGCCGAGGCGTTGCGCGCTCTGGGCACGGTTTACCCGGTCCGGGTCAACGCCGCCGCCGTCGACCTGGTCGCGGCGGTGCCGGCGGCGGGGGTCGACGTCGCGCTCGTGCTCAAGACCCTCACCACCGTGGAGCAGCAGCGCGGCGGTGCCGCGCAGCGGCTCATAGCCGCGCTCGACTGCCGTCACGTCGTGGTGAGCCTGCCCCGGCGCAGCCTGTCCGGGCGGCGCGGGTACGCCGACGACCCCGACGCGATCGTCCAACGGGCGGTTCACGGTACCGGATACGAGGTCGTCGACGAGGCGGCGTTCGGCACCGAGGCGCTGTACCACCTCGTGCCGTTGGCCGGTACCGCCGGACGCCCCGCTCCGGCGGAGGGCGCGGCGGAGCCGGGCGCCACCCGTCCGGTCGTCGACGTGCCGGCCACCGCGCGACCCGACGCCGATCGGGTGGACCCGACGGGGTAG	MARSTETRVDLAAEVARQVLAAAKYRNLDPAFVERLAQEAAERFRDRGQAVKYAKRKLHQAFGAFVAGTPAQAVAACVAKIAAGAEPKEAGREAMRAHASSAERVDWLEPFYERVAQWCGPASSVIDLACGLNPLAVPWMALAPGATYACYDVDRTMAEALRALGTVYPVRVNAAAVDLVAAVPAAGVDVALVLKTLTTVEQQRGGAAQRLIAALDCRHVVVSLPRRSLSGRRGYADDPDAIVQRAVHGTGYEVVDEAAFGTEALYHLVPLAGTAGRPAPAEGAAEPGATRPVVDVPATARPDADRVDPTG	MDKNDVVKKILESKKYENLDSDIVEKVVSISEKKYKLKEVENYSKKKLHQIWGSYYSAYPNWDKLLKKYNQGQLSIEDLLKIHSSTNERVATLNDFYTYVFGNIKHVSSILDFGCGFNPLALYQWNENEKIIYHAYDIDRAEIAFLSSIIGKLKTTIKYRFLNKESDVYKGTYDVVFLLKMLPVLKQQDVNILDFLQLFHTQNFVISFPIKSLSGKEKGMEENYQLWFESFTKGWIKILDSKVIGNELVYITSGFQK	121.01	gnl|BL_ORD_ID|1320|hsp_num:0	1405		
BGC0000695.1|Fortimicin_30 # 32936 # 33877 # 1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.721	BGC0000695.1|Fortimicin_30 	32936	33877	+	Loose	480	26.5646	adeR	27.45	3000553	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGGCTTCGATACAGTTGGCCCGGACGACACGGGGGGGCGACGGGGTGGCAAGGGCGGACGGAACGCGGCAGGCAGACGAGGCCGGTTCCGGCACCCTCTACCTGGTGCCCACCCCCATCGGCAACCCCGGGGACATCACTCTCCGGGCCATCGAGGTGCTGCGCCGGGTCGGCGTCGTGGCCTCGGAAGACACGCGGCACACCTACCGGCTGTTCCAGTCCCTGGAGATCGACGCCCGCCTGGTGAGCTACCACGACCACAACGAGGAGTCCCGCAGCCGGCAGTTGCTGGGTCTGCTCCGGGAGGGCACGGACGTCGCGCTCGTCTCCGACGCCGGGACTCCTCTGGTCAACGATCCGGGCTACCGGCTGGTAGCGGCTGCGGTCGAGGCCGACGTGCCGGTCCGGCCGCTGCCGGGCGCGACCGCCTCGGTGACCGCGCTGATCGGTTCCGGGATGCCCAACCACCAGTTCCACTACGTCGGGTTCCTGCCCCGGAAGGAGGCGGCGCGCCGGGCTGCGCTGACCGCCCTGCGGTCGACACCGGCCACGCTGATCTTCTTCGAGGCACCCCACCGGATCGTCGCGATGTTGGCCGACCTCGCCGCGGTGCTCGGTGACCGGCCGGCGGCGCTGGCCCGCAACCTGACCAAGGACGACGAGGAGTTCCTCCGCGGCCGGCTCAACGAACTGACCGCCCGGCTCCGTGTGGAGCAGGTGGTCCGGGGGCAGTTCACGGTGGTCGTCGCCGGTTCCCCCGAGGCGCATGCGGACGAGGACCGCGCCCTGGCCGCGCGCCTCACCGAGACGCTGGTGCGCCACGGTGCCGAGGCCCGGCTAATCCGCGAGGTGGTCCGGGAGGTGACCGGGCTACCGCGCAACTGGGTGTACGAGCAGGTGCGGCTGGCCACCGAACGGTCGGGTCCCCTCGGGAACAGCTGA	MASIQLARTTRGGDGVARADGTRQADEAGSGTLYLVPTPIGNPGDITLRAIEVLRRVGVVASEDTRHTYRLFQSLEIDARLVSYHDHNEESRSRQLLGLLREGTDVALVSDAGTPLVNDPGYRLVAAAVEADVPVRPLPGATASVTALIGSGMPNHQFHYVGFLPRKEAARRAALTALRSTPATLIFFEAPHRIVAMLADLAAVLGDRPAALARNLTKDDEEFLRGRLNELTARLRVEQVVRGQFTVVVAGSPEAHADEDRALAARLTETLVRHGAEARLIREVVREVTGLPRNWVYEQVRLATERSGPLGNS	MFDHSFSFDCQDKVILVVEDDYDIGDIIENYLKREGMSVIRAMNGKQAIELHASQPIDLILLDIKLPELNGWEVLNKIRQKAQTPVIMLTALDQDIDKVMALRIGADDFVVKPFNPNEVVARVQAVLRRTQFANKATNKNKLYKNIEIDTDTHSVYIHSENKKILLNLTLTEYKIISFMIDQPHKVFTRGELMNHCMNDSDALERTVDSHVSKLRKKLEEQGIFQMLINVRGVGYRLDNPLAVKDDA	126.72	gnl|BL_ORD_ID|424|hsp_num:0	456		
BGC0000695.1|Fortimicin_31 # 33910 # 34266 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=8bp;gc_cont=0.697	BGC0000695.1|Fortimicin_31 	33910	34266	-	Loose	900	23.8682	PmpM	43.48	3004077	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; aminoglycoside antibiotic; benzalkonium chloride	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGGAGATCTTCCGGGAGTTCACCTTCGAGGCCGCGCACCGGCTGCCGAACGTGCCCGAGGGGCACAAGTGCGCCCGGCTGCACGGTCACTCGTACCGGGTGACGGTGCACGTCAGCGGCGACGTCGACCCGCACAGCGGCTGGGTGATGGACTTCGGCGACCTCAAGAAGGCGGTCGAGCCGATCCGCGACCGGCTCGACCACCACTACCTGAACGAGGTGCCGGGGCTGGAGAACCCGACCAGCGAAGTGCTGGCCCGCTGGATCTGGGACCGGCTGGCCGGGTCGCTGCCGCTGTCGGCGGTGGGAGTCCGGGAGACCTGCACCTCTGGCTGCGTCTACCGCGGCGACCGCTGA	MEIFREFTFEAAHRLPNVPEGHKCARLHGHSYRVTVHVSGDVDPHSGWVMDFGDLKKAVEPIRDRLDHHYLNEVPGLENPTSEVLARWIWDRLAGSLPLSAVGVRETCTSGCVYRGDR	MNSPALPLSRGLRIRAELKELLTLAAPIMIAQLATTAMGFVDAVMAGRASPHDLAAVALGNSIWIPMFLLMTGTLLATTAKVAQRHGAGDQPGTGPLVRQALWLALLIGPLSGAVLWWLSEPILGLMKVRPELIGPSLLYLKGIALGFPAAALYHVLRCYTNGLGRTRPSMVLGIGGLLLNIPINYALIYGHFGMPKMGGPGCGWATGSVMWFMFLGMLFWVNKASIYRASQLFSRWEWPDRATIGPLVAVGLPIGIAVFAESSIFSVIALLIGGLDENVVAGHQIALNFSALVFMIPYSLGMAVTVRVGHNLGAGLPRDARFAAGVGMAAALGYACVSASLMLLLREQIAAMYSPDPAVIAIAASLIVFSALFQFSDALQVTAAGALRGYQDTRVTMIMTLFAYWGIGLPVGYSLGLTDWFQEPTGPRGLWQGLVVGLTGAAIMLCIRLARSARRFIRQHERLQREDAEAASVLGR	24.74	gnl|BL_ORD_ID|2443|hsp_num:0	2734		
BGC0000695.1|Fortimicin_32 # 34266 # 34904 # -1 # ID=1_32;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.714	BGC0000695.1|Fortimicin_32 	34266	34904	-	Loose	750	23.8682	smeD	55.56	3003055	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; tetracycline antibiotic; phenicol antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGTACCGGGTCAAGGAGATCTTCTACACCCTGCAGGGTGAGGGCAGCCACGCCGGCCGACCGGCGGTGTTCTGCCGCTTCACGAGCTGCAACCTCTGGACCGGGCGGGAGGAGGAGCGGCACCGGGCGATCTGCCAGTTCTGCGACACCGACTTCGTCGGCACGGACGGCCCCGGCGGGGGCCGCTTCGCCACCGCAGCCGAGCTGGCCGCAGCGGTCGTCGCCGCCTGGCGGGGCGAGGACCACCCGCGCAGCCGCCCATACGTGGTGTGCACCGGCGGCGAGCCACTGTTACAACTCGACGAGGCGGCCGTACGGGCCCTGCACGACGCGGGCTTCGAGGTCGCGGTGGAGACCAACGGCACCCGCCCCGCGCCGCCCGGCATCGACTGGGTCTGCGTCAGCCCCAAGGCGGGCGCGGACCTGGTGCTCACCCGTGGCGACGACCTGAAGCTCGTCTACCCGCAGCCGGGTGCCGAGCCGGCCCGCTTCGAGGGCCTGGACTTCGCGCACTTCATGCTGCAGCCGATGGACGGCCCCGACCGGGTCGCCAACACCGAAGCCGCGGTGCGGTACTGCCTGGAGCACCCGCAGTGGCGATTGAGCCTGCAGACCCATAAGTACATAGGAATCGCCTGA	MYRVKEIFYTLQGEGSHAGRPAVFCRFTSCNLWTGREEERHRAICQFCDTDFVGTDGPGGGRFATAAELAAAVVAAWRGEDHPRSRPYVVCTGGEPLLQLDEAAVRALHDAGFEVAVETNGTRPAPPGIDWVCVSPKAGADLVLTRGDDLKLVYPQPGAEPARFEGLDFAHFMLQPMDGPDRVANTEAAVRYCLEHPQWRLSLQTHKYIGIA	MLLSRIRPFALSLAIAATVAACGGQPQAPEQGPGDVTVVTLKSETVGLTRELPGRTNAFLVAEVRPQVNGIVAKRLFTEGGMVKAGEPLYQLDDASYRAQANNARAQLARAEATANAARLSAKRITELAKVDAVSQQDLENAVAAQKQAEADVGAAKASLDAANVTLGYARITAPISGRIGKSSVTQGALVSAGQANALATVQQLDPIYVDLTQSSAELLQLRRELAAGRLQDNQTLPVSILMEDGSTFEHKGTLEFSEVSVDPTTGSFGLRVKVDNPDGLLMPGMYVRAVIGGGVRSDAVLVPMQGIARDPKGDTTAMVVGKDNKVEVRPVKVSRTVGDKWLVEDGLKAGDKVIVEGLQKIGPGMPVKATEKGDAPAKPAAAAQPAAPAGDAK	53.81	gnl|BL_ORD_ID|263|hsp_num:0	284		
BGC0000695.1|Fortimicin_34 # 35788 # 36138 # 1 # ID=1_34;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=10bp;gc_cont=0.735	BGC0000695.1|Fortimicin_34 	35788	36138	+	Loose	2000	22.7126	adeB	32.14	3000775	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	TTGACGGGCTGCTCCGCCGGCTCGGGTCGGGCCGCCGCTGCCGAATCGAACGGCCTGGCGGTCGCCGGCATGGTAAAGAGGTTCCCCGGGACCCGGGGCAGGCCGTTGGGCAGCAGCGGCACCGCCATGGCCGTGGTGACGAGGGCCATCAGCACCAAGGTCGGAGTGTACGGAATCCATCTGGGTTCCTCGGCTCTTTTGGCACGGACGCCGGTAGAGAGGCCGGAAGCCGGCGCCCCGCCAAGTGCGAGGCACCGCTCCGCCCGGCCGGGCGGGACGGCGACCGGCCCTGGTGGTGAGCGGTGCGACGGCCAGGGACGGCCGGAGCACCGCAGCCAGGGCGCGGCATAG	MTGCSAGSGRAAAAESNGLAVAGMVKRFPGTRGRPLGSSGTAMAVVTRAISTKVGVYGIHLGSSALLARTPVERPEAGAPPSARHRSARPGGTATGPGGERCDGQGRPEHRSQGAA	MSQFFIRRPVFAWVIAIFIIIFGLLSIPKLPIARFPSVAPPQVNISATYPGATAKTINDSVVTLIERELSGVKNLLYYSATTDTSGTAEITATFKPGTDVEMAQVDVQNKIKAVEARLPQVVRQQGLQVEASSSGFLMLVGINSPNNQYSEVDLSDYLVRNVVEELKRVEGVGKVQSFGAEKAMRIWVDPNKLVSYGLSISDVNNAIRENNVEIAPGRLGDLPAEKGQLITIPLSAQGQLSSLEQFKNISLKSKTNGSVIKLSDVANVEIGSQAYNFAILENGKPATAAAIQLSPGANAVKTAEVVRAKIEELKLNLPEGMEFSIPYDTAPFVKISIEKVIHTLLEAMVLVFIVMYLFLHNVRYTLIPAIVAPIALLGTFTVMLLAGFSINVLTMFGMVLAIGIIVDDAIVVVENVERIMATEGLSPKDATSKAMKEITSPIIGITLVLAAVFLPMAFASGSVGVIYKQFTLTMSVSILFSALLALILTPALCATILKPIDGHHQKKGFFAWFDRSFDKVTKKYELMLLKIIKHTVPMMVIFLVITGITFTGMKYWPTAFMPEEDQGWFMTSFQLPSDATAERTRNVVNQFENNLKDNPDVKSNTTILGWGFSGAGQNVAVAFTTLKDFKERTSSASKMTSDVNSSMANSTEGETMAVLPPAIDELGTFSGFSLRLQDRANLGMPALLAAQDELMAMAAKNKKFYMVWNEGLPQGDNISLKIDREKLSAFGVKFSDVSDIISTSMGSMYINDFPNQGRMQQVIVQVEAKSRMQLKDILNLKVMGSSGQLVSLSEVVTPQWNKAPQQYNRYNGRPSLSIAGIPNFDTSSGEAMREMEQLIAKLPKGIGYEWTGISLQEKQSESQMAFLLGLSMLVVFLVLAALYESWAIPLSVMLVVPLGIFGAIIAIMSRGLMNDVFFKIGLITIIGLSAKNAILIVEFAKMLKEEGMSLIEATVAAAKLRLRPILMTSLAFTCGVIPLVIASGASSETQHALGTGVFGGMISATILAIFFVPVFFIFILGAVEKLFSSKKKISS	11.21	gnl|BL_ORD_ID|817|hsp_num:0	866		
BGC0000695.1|Fortimicin_35 # 36526 # 36987 # -1 # ID=1_35;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.656	BGC0000695.1|Fortimicin_35 	36526	36987	-	Loose	600	27.7202	emrK	24.59	3000206	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGGAGCCGGAAGACGTCCAGGACGTGTTGGATGCGGTGGTCAAGGTCCGAGACGATCTGGGGAGCGACGAAGCGGAGCCTGATCGGTCCATGGCTCTGACGAAGCTCGGTCGGGCGAACACCCCGCCCGACCGATCCCTCGAAACCTTCCCGATCGGCGACAGCTCGCAGGAGATCACCATCGACTGCCGGGAGTTCACCTGCCGCTGCCCCATCACCGGGCAGCCGGACTGGGCGACGATCCGGATCGACTACCGCCCCGGGGACCGGGGAGTGGAGACGAAGAGTCTCAAGCTCTACCTGGAGACCTTCCGGGACGAGGGGATCTTCCACGAGCACCTGGCGACGAAGATGCGTGACGACCTGGTGGCCACTCTCGAGCCGGTCTTCCTGAAGGTCACGGTCAACTTCAACGTCCGGGGCGGCATCGCGCTCGCCGCGTCGAGCACGTACGAGCGCTGA	MEPEDVQDVLDAVVKVRDDLGSDEAEPDRSMALTKLGRANTPPDRSLETFPIGDSSQEITIDCREFTCRCPITGQPDWATIRIDYRPGDRGVETKSLKLYLETFRDEGIFHEHLATKMRDDLVATLEPVFLKVTVNFNVRGGIALAASSTYER	MELEDMISTDDAYVTGNADPISAQVSGSVTVVNHKDTNYVRQGDILVSLDKTDATIALNKAKNNLANIVRQTNKLYLQDKQYSAEVASARIQYQQSLEDYNRRVPLAKQGVISKETLEHTKDTLISSKAALNAAIQAYKANKALVMNTPLNRQPQVVEAADATKEAWLALKRTDIKSPVTGYIAQRSVQVGETVSPGQSLMAVVPARQMWVNANFKETQLTDVRIGQSVNIISDLYGENVVFHGRVTGINMGTGNAFSLLPAQNATGNWIKIVQRVPVEVSLDPKELMEHPLRIGLSMTATIDTKNEDIAEMPELASTVTSMPAYTSKALVIDTSPIEKEISNIISHNGQL	43.59	gnl|BL_ORD_ID|570|hsp_num:0	609		
BGC0000695.1|Fortimicin_36 # 37061 # 37372 # 1 # ID=1_36;partial=00;start_type=TTG;rbs_motif=GGA;rbs_spacer=11bp;gc_cont=0.577	BGC0000695.1|Fortimicin_36 	37061	37372	+	Loose	500	155.606	sgm	80.9	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	TTGGGGAGATCCGCTCGCCGTACCGCTCCCGGATCGCCGGCCAGTCGCCTTGACGAGCCGGCCGACGTCACGCTATTGCTCAAGACGCCCCCCTGTCTGGACACTCAACAACGCGGTGGCGGATGGGAAGTTATTGACATTGTCAACTCACCAATTGTTGTGGCAACCCTCCCGACCAGGTCGCTTGGGCGGCAATCGAAGGGCATGTCGCAGAACTACTCACAGAGTTTTGAGTTGCAGGCCAAAGAGCGGTCGTGCCGAATTCACCGACTGGAGATCGGCAACGAGCTGATTTACATCGTCCAAAAATAG	MGRSARRTAPGSPASRLDEPADVTLLLKTPPCLDTQQRGGGWEVIDIVNSPIVVATLPTRSLGRQSKGMSQNYSQSFELQAKERSCRIHRLEIGNELIYIVQK	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	37.59	gnl|BL_ORD_ID|1952|hsp_num:0	2079		
BGC0000695.1|Fortimicin_37 # 37713 # 38534 # -1 # ID=1_37;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.746	BGC0000695.1|Fortimicin_37 	37713	38534	-	Loose	500	116.316	sgm	30.19	3000862	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic target alteration	16S rRNA methyltransferase (G1405)	GTGAGGCGACCGGTGACGACGTCCCCGCCCGCCGTCGAGAAGGTCCTCGCCCGGCTCACCGCCGCCGCCAAGTACCGGAACGTGCACCCGGAGACCATCGCCGACCTGGTCCGATGGGAGGCGCGGGCCACCGGTGACCCGGCCGAACTGGAGCGCCTGGTCCGGGCCCGGCTGCACAAGGTGGCCGCCCTGCACCTGCTCACCGCGCGGCCCGCCGCGCTGCGCAAGGCGCTGGACCGGGCCGACCTCGCCGACCCGGGGGCCCGGCGGGAGTGGTGCCGGCAGGTGCTGGCCGGTCACTTCTCCTCGGCCGAGCGCCTGCCCGACCTGGACGCCTTCTACCCGGCCCTGTTCGGGCTGGTGCCGCCGCCGCGTACGGTGGCCGACCTCGCCTGCGCGCTGAACCCGTTCAGCCTGCCGTGGCTGCGGGACGTGACCGACGCCCGGTACGTCGGCTACGACTTCAACTCGTCGTTCGTCGCGCTGGGCAACGCCTTCCTCGCCCGCGCCTGCCCCGAGAGCGAGGTCCGGCACGGGGACGTGCTCAGCGGCGACCACGAGGTGACCGCGGACCTGGCGCTGCTGCTGAAGACGTACCACTGCATGGAGGGACGCAGGCCCGGTGCGGGCCTGGCGCTCGTCGACCGGCTGGCGTGCCGGCACGTGGTGGTGTCGTTCCCGACCCGCGCCATGAACGGCCGGGCGGCGGTCTTCGTCCCCCGGCACCTGGAGGAGCTGGCCGAGCTGGCCCGCGACCGGGGTTGGAGCTGGTCGCGGGTCACGCTCGACACCGAGGACCTGGTGGCGATCGGCAAGGGCTGA	MRRPVTTSPPAVEKVLARLTAAAKYRNVHPETIADLVRWEARATGDPAELERLVRARLHKVAALHLLTARPAALRKALDRADLADPGARREWCRQVLAGHFSSAERLPDLDAFYPALFGLVPPPRTVADLACALNPFSLPWLRDVTDARYVGYDFNSSFVALGNAFLARACPESEVRHGDVLSGDHEVTADLALLLKTYHCMEGRRPGAGLALVDRLACRHVVVSFPTRAMNGRAAVFVPRHLEELAELARDRGWSWSRVTLDTEDLVAIGKG	MTAPAADDRIDEIERAITKSRRYQTVAPATVRRLARAALVAARGDVPDAVKRTKRGLHEIYGAFLPPSPPNYAALLRHLDSAVDAGDDEAVRAALLRAMSVHISTRERLPHLDEFYRELFRHLPRPNTLRDLACGLNPLAAPWMGLPAETVYIASDIDARLVGFVDEALTRLNVPHRTNVADLLEDRLDEPADVTLLLKTLPCLETQQRGSGWEVIDIVNSPNIVVTFPTKSLGQRSKGMFQNYSQSFESQARERSCRIQRLEIGNELIYVIQK	99.64	gnl|BL_ORD_ID|1952|hsp_num:0	2079		
BGC0000695.1|Fortimicin_39 # 40025 # 41155 # 1 # ID=1_39;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=6bp;gc_cont=0.737	BGC0000695.1|Fortimicin_39 	40025	41155	+	Loose	1900	26.9498	TriC	31.46	3003681	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCGGCTTGTCCGTCTCTGACCACCTGGACGGTCAGTTGGCGCGCCTGTGCGAGGTTGCCGGGGCCGATCCTGTCGAACCTCGGAACCTGTTGGCGGGCCTGCTCGGCCCCGTCGGCCCGCGTCCACTGTACGAACCGCCGGCCTGGCCGTCCGGCGTCTCCGACGACCATACGCCGGTCGAGTTCTCCATCGCCTTCAACGAGGCGGAGCCCCCGACGTTGCGGATCCTGGGTGAGACGCTGGGATCGCCGCCCGGCCCGCTGGCCAACCTGTCCGCCACGCGCGGCTTCCTCGACGCGCAGGCCCGCCGGGCCGGCCTGTCGACGTCCCGGCTGGACTCGGTGCGGGATCTGTTCGCCACCGATGATCCGCAGGGCGACTTCGCCATGTGGTGCTCGCTGGTCTTCCGCAGCAGCCGGCGACCCGAGTTCAAGGTCTACCTCAACCCGGAGGTCAAGGGGGTCGAGCGGTCGCCCGCCCTGGTGTCCGAGGCCCTGCACCGGCTCGGGCTCGGCGCGTCGTACCGGGCGCTGCTCGACCACGGCGTCCGGCCGGGGGAGCTGGGCCGCGGCGACCGGCTGACGTTCTTCGCCGTCGATCTGCACGACGGGCCGCAGGCCCGGGTCAAGCTCTACCTGACCCACCACGAGGCCGAGGTCTGGGACGTGACGCGGGCGGCCAGCGTGGTCGACGGCGTCGACGTGGCGGAGATCGAGGAGTTCTGCGTGGTGGCCGGCGGCGGCACGCGCCGCTTCGACGGCCGCCCGCTCGTGGGCAGCTACACCTTCACGGAGGGCGCCGACCGGCCGGTCGGCTACAGCATCTACGTGCCCATCCGCAGCTACGTCACCGACGACCAGGAGGCCCGCGACCGGGTCGCGGCGTTGCTGGTCCGCTACGGGTTCGACACCGACGGGCTGGACCGGGCGATCGCCGCCGTGACGCCCCGGCCGCTCCGCGACGGCGTCGGACTGATCGCGCACGTCTCGCTGCGGCTGGGCGCGCCCCGGCCGGGTGTGACCGTCTACCTGTCGGCCGAGGCGTACCGGGTGAGCCCGCCGCGTCCGCGGCGGATGCCCGCCGGCCGCGACGTGTCGCCGGCTCCGGTCGGCCGTACCCGACCCTGA	MAGLSVSDHLDGQLARLCEVAGADPVEPRNLLAGLLGPVGPRPLYEPPAWPSGVSDDHTPVEFSIAFNEAEPPTLRILGETLGSPPGPLANLSATRGFLDAQARRAGLSTSRLDSVRDLFATDDPQGDFAMWCSLVFRSSRRPEFKVYLNPEVKGVERSPALVSEALHRLGLGASYRALLDHGVRPGELGRGDRLTFFAVDLHDGPQARVKLYLTHHEAEVWDVTRAASVVDGVDVAEIEEFCVVAGGGTRRFDGRPLVGSYTFTEGADRPVGYSIYVPIRSYVTDDQEARDRVAALLVRYGFDTDGLDRAIAAVTPRPLRDGVGLIAHVSLRLGAPRPGVTVYLSAEAYRVSPPRPRRMPAGRDVSPAPVGRTRP	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	37.04	gnl|BL_ORD_ID|2049|hsp_num:0	2194		
BGC0000695.1|Fortimicin_40 # 41180 # 42595 # 1 # ID=1_40;partial=00;start_type=ATG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.719	BGC0000695.1|Fortimicin_40 	41180	42595	+	Loose	500	25.7942	MSI-OXA	29.09	3003719	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	MSI-OXA family beta-lactamase	ATGGACGTGCGAAAGGCCCTGCCCGCCGTACCGATCAAGGTCGTCGAACCGATCCCCTTCCTCACCGCGGAGGAACGCCGGCGGGCGCTCGCGGATGCCGGATACAACCCGTTCAACCTGCGCGCCGACCAGATCACCATCGACCTGCTGTCCGATTCCGGCACCGGCGCGACGTCGGCGGCGCAGGAGGCGGCCGCCGCGCTGGGCGACGAGTCGTACGCCGGCGCGCGATCGTGGTTCCGGTTCCGGGACGAGGTGCGCGACCTCACCGGATACCCGCGGATCCTGCCGGTCCACCAGGGCCGGGCCGGCGAGCGGGTCCTGTTCGGCAGCCTGCTGAAGCCCGGCCAGATCTGCATCAGCAACACCCACTTCGACACCACCCACGCGAACGTCCTGCTCGCCGGGGCGGAACCACGGGACCTCCCGTGCAACGAGGCGGCCGACCTCGACAGCGACGAACCGTTCAAGGGCAACATCGACCTGGCCGCGCTCGAACGCACCCTTGCCGGGCCCGAGGGGCACCGGGTCGGCCTGGTGCTGATGACCATCACCAACAACGGCCTCGGCGCGCAGCCGGTCTCCATGGCCAACCTCGCGGCCGTACGGGAGCTGTGCCGGCGCCACCGCGTGCCGTTCTTCCTGGACGCGGCGCGCTTCGCCGAGAACGCCTGGCTGGTCAACCAGCGGGAAGCGGGCTACGGGACGTGGACCCCGCGGCAGATCGCCACCCGCGCGTTCCAGCTCGCCGACGGCTGCGTGGTGAGCCTGAAGAAGGACGGCCTGGCGGCCATCGGCGGGTTCATCGGGCTCCGCGACGACGAGTTGCACGCCGCGTGCGAGGCGAACCTGATCGCGACCGAGGGATTCTCCACCTACGGCGGGCTCGCCGGCCACGACCTCGAACGGCTCACCCAGGGGCTGCGCGAGGTGGTCGATCCCGCGTACCTGCGCGCCCGTGCCGCGTCCACCGAACGGCTGGCCGAGCTGCTCGACGACGTGGGCGTCGACACCGTCCGACCGGCGGGCATCCACGCCCTGTACCTCAACGCCGGCCGGCTGCTGCCGCACCTGTCCCCGCGGGAGTTCCCCGGGCACGCCCTGGGCTGCCAGCTCTTCCTCGACGGCGGGATCCGCTGCGCCGAGCTGGGATCGCTCTACCTGGGCGAGATGGACGAGCACCACCGGCTGCTCACTCCCGCTCCCTTCGAGCTGGTGCGGCTGGCGATCCCGCGCCGGGTCTACACCGACACGCACCTGGAGTACGTGGCCGCCGTCCTCGCCGACATCGCGAAGGACCCCGAGCAGGTCAGCGGGTACCGGATCGTCTCGGCGCCGCCCCTGCTGCGCCACTTCAAGGTGCGGTTGGAGCCGCTGCCGCCGGCGGCGGGCAGGTCCGTGGCCAGCTACGGCTGA	MDVRKALPAVPIKVVEPIPFLTAEERRRALADAGYNPFNLRADQITIDLLSDSGTGATSAAQEAAAALGDESYAGARSWFRFRDEVRDLTGYPRILPVHQGRAGERVLFGSLLKPGQICISNTHFDTTHANVLLAGAEPRDLPCNEAADLDSDEPFKGNIDLAALERTLAGPEGHRVGLVLMTITNNGLGAQPVSMANLAAVRELCRRHRVPFFLDAARFAENAWLVNQREAGYGTWTPRQIATRAFQLADGCVVSLKKDGLAAIGGFIGLRDDELHAACEANLIATEGFSTYGGLAGHDLERLTQGLREVVDPAYLRARAASTERLAELLDDVGVDTVRPAGIHALYLNAGRLLPHLSPREFPGHALGCQLFLDGGIRCAELGSLYLGEMDEHHRLLTPAPFELVRLAIPRRVYTDTHLEYVAAVLADIAKDPEQVSGYRIVSAPPLLRHFKVRLEPLPPAAGRSVASYG	MSHTFIIDRLGASMIKQILAALLLISPLLAQAAEWKESAQVARLFKQEGVSGTFVVYDVAADSYTVHDRQRANTRFIPASTFKIPNTLIALAHGAVANVDEVVPYGGKPVARPEWARDMGLREAIRISNVPVYQEVARRVGLDRMRSELVRMKYGNMQTGTVVDRFWLDGPLKISAVEQTEFLTKLAQGTLPFTNVAMAAVREISRQDGAPELYAKTGWGSRPGEADIGWWVGWLKKDGKLYAFALNMDLPDGAQDKRVSLAKAALRELGLL	173.16	gnl|BL_ORD_ID|2077|hsp_num:0	2234		
BGC0000695.1|Fortimicin_41 # 42675 # 43262 # -1 # ID=1_41;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=3bp;gc_cont=0.696	BGC0000695.1|Fortimicin_41 	42675	43262	-	Loose	800	27.7202	msrA	47.62	3000251	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	GTGGCCTCGAACGACTCCGACCGCGGGCCCTACGTGGATCGGAAATCGGTCAAGGTCGTTGTGGCGGGCGGCTTCGGCACCGGCAAGACCACCTTGGTCGGATCGGTCAGTGAGATCCCGCCGTTGGTCACGGAGGAGGTCCTGACCCAGGCCAGCGTCGGCGTGGACGACATCACGGGCATCGAGGGCAAGGCGAGCACGACCGTCGCCCTGGACTTCGGCCGCATCACCATCGCCCCGGACGTCGTGCTCTACCTGTTCGGCACGCCGGGGCAGGACCGGTTCTGGTTCATCTGGGACGAGCTCGCGCAGGGCGCGGTGCGGCGCGATGTGCTGGTCGACACGAGGAGGCTCGGGACGAGCTTCCCCGCCATCGACTACTTCGAGCGGCGGGGCATCCCCTTCCTGGTCGCCGTCAACCGGTTCCACAGCGAGTGCCTGTACAGCGCCGACGAGATCCGGGCGGCGCTGGAGCTGGACCCGGCCGTACCGCTGCTCTGGTGCGACGCCCGGGACCGGGAGTCCAGCAAGCAGGCGCTGATCGAGCTGGTCCGGCACGCCCTGTCGCGCCTGGCGGTCGGCGCCTGA	MASNDSDRGPYVDRKSVKVVVAGGFGTGKTTLVGSVSEIPPLVTEEVLTQASVGVDDITGIEGKASTTVALDFGRITIAPDVVLYLFGTPGQDRFWFIWDELAQGAVRRDVLVDTRRLGTSFPAIDYFERRGIPFLVAVNRFHSECLYSADEIRAALELDPAVPLLWCDARDRESSKQALIELVRHALSRLAVGA	MEQYTIKFNQINHKLTDLRSLNIDHLYAYQFEKIALIGGNGTGKTTLLNMIAQKTKPESGTVETNGEIQYFEQLNMDVENDFNTLDGSLMSELHIPMHTTDSMSGGEKAKYKLRNVISNYSPILLLDEPTNHLDKIGKDYLNNILKYYYGTLIIVSHDRALIDQIADTIWDIQEDGTIRVFKGNYTQYQNQYEQEQLEQQRKYEQYISEKQRLSQASKAKRNQAQQMAQASSKQKNKSIAPDRLSASKEKGTVEKAAQKQAKHIEKRMEHLEEVEKPQSYHEFNFPQNKIYDIHNNYPIIAQNLTLVKGSQKLLTQVRFQIPYGKNIALVGANGVGKTTLLEAIYHQIEGIDCSPKVQMAYYRQLAYEDMRDVSLLQYLMDETDSSESFSRAILNNLGLNEALERSCNVLSGGERTKLSLAVLFSTKANMLILDEPTNFLDIKTLEALEMFMNKYPGIILFTSHDTRFVKHVSDKKWELTGQSIHDIT	39.96	gnl|BL_ORD_ID|1132|hsp_num:0	1200		
BGC0000695.1|Fortimicin_42 # 43274 # 43639 # -1 # ID=1_42;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.661	BGC0000695.1|Fortimicin_42 	43274	43639	-	Loose	800	27.335	adeG	39.02	3000778	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGTACGACGTGTGGGACGGCGACGACGAGGCGGAGGCCGGGCGGCTCGTTCCCCTGTACATCCTGGTCAACGGCCGGACGAGTCCACGCAACAGCAACCTGGACCTGGCCACCCAGGGTCATCGCGCTGCCCGCCGACACACACGTTTGGAGTGGGAGTACCGGGAGATCGTCAGCCGCTGCGCCACCTGGATCTCCATTGCCGAGATCGGCGCCTACCTGCACAGACCGCTGACCATCACCAAGGTGATGGTCGACGTGCTGGTCGAGCAGGGGTTCCTGGACATCGGATCCCCGGCGCAGCAGAAGATCGCGGATCGTCGGCTGCTGGAAACCGTTCTCGCCGGCCTGCAGCGGCTCTAG	MTYDVWDGDDEAEAGRLVPLYILVNGRTSPRNSNLDLATQGHRAARRHTRLEWEYREIVSRCATWISIAEIGAYLHRPLTITKVMVDVLVEQGFLDIGSPAQQKIADRRLLETVLAGLQRL	MSFSRKQFALSAIFVAILATGGSFMLLHENADAKAAPTAAQQAATVDVAPVVSKTITDWQEYSGRLEAIDQVDIRPQVSGKLIAVHFKDGSLVKKGDLLFTIDPRPFEAELNRAKAQLASAEAQVTYTASNLSRIQRLIQSNAVSRQELDLAENDARSANANLQAARAAVQSARLNLEYTRITAPVSGRISRAEVTVGNVVSAGNGAQVLTSLVSVSRLYASFDVDEQTYLKYISNQRNSAQVPVYMGLANETGFTREGTINSIDNNLNTTSGTIRVRATFDNPNGVLLPGLYARIRLGGGQPRPAILISPTAVGVDQDKRFVVVVDAKNQTAYREVKLGAQQDGLQIVNSGLQAGDRIVVNGLQRIRPGDPVTPHLVPMPNSQITASATPPQPQPTDKTSTPAKG	29.80	gnl|BL_ORD_ID|1155|hsp_num:0	1226		
BGC0000695.1|Fortimicin_43 # 43636 # 44106 # -1 # ID=1_43;partial=00;start_type=TTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.682	BGC0000695.1|Fortimicin_43 	43636	44106	-	Loose	3000	25.0238	abcA	24.42	3003942	protein homolog model	n/a	n/a	cephalosporin; penam; peptide antibiotic	antibiotic efflux	ATP-binding cassette (ABC) antibiotic efflux pump	TTGAAGGTCATCGAGGACCTGCAGATCCGTAGGGCGAATTTCGTGAACTCGACACCTCAGACCGATCTGACCTGGATCCTGGACGATCTCGTGGAGGTCCCCGACGTCGTCTACGCACTCGTCCTGTCCACCGACGGGCTGATCGTCCAGAAGTCCACGTCGCTGGCGCAGGACGCCGGTGAGCTGCTGGCGGCCGGCGCGTCGTCGCTGTACAGCGTGGCGGCCGGTATGGGTCGCCGCTTCGACAGCGGGCCGGTGCAGCAGGTCATCATCGAGTACCGGGGCCGCACCCTGTTCGTCGCCGCCGCCGGCCAGAACGCGCGGCTGGCCGTGCTGTGCGAGCAGTCGGTCGACATGGGCACGGTCGCCTACGAGATGAGCCGGCTGGTGACCCGCATCGGCGAGTACCTCGGCTCGGAGGCCCGACCGCCCGTCCTGCCGCTCAGCGAGTCCGTCGGGCTACGACCATGA	MKVIEDLQIRRANFVNSTPQTDLTWILDDLVEVPDVVYALVLSTDGLIVQKSTSLAQDAGELLAAGASSLYSVAAGMGRRFDSGPVQQVIIEYRGRTLFVAAAGQNARLAVLCEQSVDMGTVAYEMSRLVTRIGEYLGSEARPPVLPLSESVGLRP	MNESHEAGKNSSTNVEEREEEVLRLARQFTEQSSYSTAGQTPFAAEAGSALDPNGERFNARAWCKAMLQMHIGDKEAHPLRTLGVAFSNLNVHGFGSDTDYQKSVGNVWLKTLSLARIAFGQKQRKVDILQNLEGLVEAGEMLVVLGPPGSGCSTFLKTIAGETYGFHVDKNSNINFQGIAKQMAHEFRGEAIYTAEVDVHFPKLTVGDTLYFAARARTPRHIPGGVNATQYAGHMRDVIMAMFGISHTKNTIVGNDFIRGVSGGERKRVSIAEACLSNAPLQCWDNSTRGLDSANAIEFCKTLRMQADINGTTACVSLYQAPQAAYDYFDKVLVLYEGREIYFGPTSMAKHYFLQMGFVCPDRQTDADFLTSMTSHLERVVQPGYEDRVPRTPDEFAARWKASPQRAQLMQHIKSYNAKFALDGEYLDKFKQSRRAQQAKAQRVSSPYTLSYVQQVKLCLWRGYQRLKADPSVTISSLFGNTIISLVIASIFYNLKADTSTFFQRGALLFFAVLMNALGCGLEMLTLYAQRGIIEKHSRYALYHPSAEAFSSMIMDLPYKILNAITSNIVLYFMTNLRREPGAFFFFVFTSFILTLTMSMFFRSMASLSRSLVQVLPFSAVLLLGLSMYTGFAIPTGYMLGWARWIAYINPISYGFESLMINEFHNRDFPCMDYVPSGPGYTDVGLNNRVCSTVRSVPGQAFVNGNAYIESAYSYTASHKWRNIGVIFAYMFLLGAVYLVATDFITEKKPKGEILVFPRGHKALKKGKSDEDLEGGGGRSATVEKIGSDGLAMIERQTAIFQWKDVCFDIKIGKENCRILDHVDGWVKPGILTALMGVSGAGKTTLLDVLATRTTMGIISGEMLVDGQPRDESFQRKTGYAQQQDLHLSTATVREALEFSALLRQSAHVPRQEKIDYVTEVIKLLDMTEYADAVIGVPGEGLNVEQRKRLTIGVELAARPQLLLFLDEPTSGLDSQTSWAILDLLDKLKKNGQAILCTIHQPSAMLFQRFDRLLFLQAGGRTVYFGEIGQNSQILIDYFVRNGAPPCPPDANPAEWMLDVIGAAPGSHTSINWFETWRRSPEYARVQEHLAELKHERRHQTNLFRTTSGQKREDKDSYREFAAPFWAQLYQVQVRVFQQIWRSPTYIYSKTALCVLSALFVGFSLFHTPNTIQGLQNQMFGIFMLLTLFGQLIQQIMPHFVAQRALYEVRDRPAKTYSWKAFLIANIVVELPWNSLMSVLMFLCWYYPIGLYRNAEPTDAVHLRGTQMWLMIWTFLLFSSTFAHFMIAAFDAAENAGNLGNLLFLLCLLFCGVLATPDQLPRFWIFMYRVSPFTYLVSGMLSVGISNTNVTCADNEYLRFDPVNGTCGEYMGSYMSNLGGYLADEMATANCSFCPIKETNVFLGRVSSSYSDIWRNFGLMWVFIVFNIFAACSLYWWVRVPRDKKPVAKAE	10.74	gnl|BL_ORD_ID|2225|hsp_num:0	2416		
BGC0000695.1|Fortimicin_44 # 44075 # 45556 # -1 # ID=1_44;partial=00;start_type=GTG;rbs_motif=GGA;rbs_spacer=12bp;gc_cont=0.706	BGC0000695.1|Fortimicin_44 	44075	45556	-	Loose	500	26.9498	OXA-427	43.48	3003115	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGCGCCCACATCGCCGTCGGCCGATTTAGCGGCCGCGAATTCGCCCTTATTCAACTTGGCGCACGAACAGGCCGACCGCGAAAGCAGGCACCGTGATTCGGACGAACACGGCCAGCCAACGGCGTCGAACCCGCGCCGGGGTCAACAGCAGTCCATCAAACGGCGCGTCATCAGGCTCGTGCTCATCCCCAGTGTCGTCGCACTGGTCATGTGGCTCGTCGCGTCCGGATACCTTATCTTCCAGGGCTTCTACAACCGCGAGGTCGCCAACAGCGTCCGCCAGGTGTCGATCCCGGCGGTGTCCGCGCTGGCCTCGCTCCAGCAGGAACGGCGGCTGAGCGTCGCCTACCTCGCGCAGCCGTCGAGGGACCTGCAGAAGCTGCTCGACCGGCGGCAGCAGACGGACCAGCGGATCGCGGCGATGCGCAGCGCGGCCGACTCGGCGTTGGGCAACGCTCCGCAGTCCATCGCGACGCAGTGGAGGACGCTGGCGGGCCACCTGGACGAGCTACCGGGCGTACGGAGCACCATCGACGCCCGGTCCGCCGACCAGCAGGGCGTGTACGACTTCTACAACGACCTGCTCGACGCCGCGACCGGGCTCTTCGACACCCAGGCCCGGATCGTCCCCGACGTCACCGCGGCCCAGGGCGGCATCGCGGCGACCGAGACCTTCCGCGCCAGCGACCTGATGTCCCGGGCCGGATCGAAGATCGACGGCGCGTTCGGCTCCCGCTCGTTCGGCCAGCAGGACTACCTCGAGTTCGTGAGCCTGGTGGGCGCCTACCACGCCGGCCTCGCCAACGTCGCCCCGCACCTGCAGGCGGATGTGCGCAGGCGCCACGAGGGGATCACGGCGGGCAGCCCCTGGAAGCAGTTGGTCGCCGCGGAGAACGCGCTCATCGCCGGCGGCCCGTGGCGGGACGGGATGCCGCGCGCGCTGCCGTTCACGAGGGCCGAGTGGGACACGCTCACGCAGCAGGTCTCCGACGACCTGATCAACCTGACCGTCGAGCAGGCCGACAAGGTCTCGGCGGAGACCCTCCGCACGGGCAACGGGCAGCTGCTGACCGCGTCCCTGGGCAGCCTCCTGGCGCTGTCCGTCGCCGTCGCCGCGATCCTGTGGGCGATCCGCCAGTCGCGGATCCTGGTCGACCGCGCGCTCTCCGTCCGCCTGGCGCAGTTGGGTAGGGACGCCGCCGCGATGGTGGACGAGCGGCTGCCGGCCATGATGGAACGCCTCCGGCGGCGCGAGAAGGTCGACGTCGCGGTCGAGCTTCCGATGCAGGACTACGGCAGCGACGAGATCGGCCAGGTCGCGCAGGTCATCAACAGGTCGCTGCAGGCCGCCGCAGGCGCGGCCGTCGACGAGGCGAAGACCCGGGCCGCCGGTGTCGCCATGCTGATGGGCGTCGCCCGCCGCCCGCAACGACCCCTCCAGCGGGGCCTTGAAGGTCATCGAGGACCTGCAGATCCGTAG	MAPTSPSADLAAANSPLFNLAHEQADRESRHRDSDEHGQPTASNPRRGQQQSIKRRVIRLVLIPSVVALVMWLVASGYLIFQGFYNREVANSVRQVSIPAVSALASLQQERRLSVAYLAQPSRDLQKLLDRRQQTDQRIAAMRSAADSALGNAPQSIATQWRTLAGHLDELPGVRSTIDARSADQQGVYDFYNDLLDAATGLFDTQARIVPDVTAAQGGIAATETFRASDLMSRAGSKIDGAFGSRSFGQQDYLEFVSLVGAYHAGLANVAPHLQADVRRRHEGITAGSPWKQLVAAENALIAGGPWRDGMPRALPFTRAEWDTLTQQVSDDLINLTVEQADKVSAETLRTGNGQLLTASLGSLLALSVAVAAILWAIRQSRILVDRALSVRLAQLGRDAAAMVDERLPAMMERLRRREKVDVAVELPMQDYGSDEIGQVAQVINRSLQAAAGAAVDEAKTRAAGVAMLMGVARRPQRPLQRGLEGHRGPADP	MSRILLSSLLAAGLFCSLPASAATGCMLFADGSGKPFSAQGDCASQLPPASTFKIPLALMGYDSGFLVDEQLPALPFKAGDPDFLPEWKQTTTPSRWMTYSVIWYSQRLTEWLGAARFQQYVDRFDYGNRDLSGNPGKHDGLTQAWLSSSLAISPQEQARFLGKLVSGKLPVSAQTLQHTANILRQPDIDGWQIHGKTGTGYPKLLDGSLDRDQQIGWFVGWASKQDQKLIFVHTVIQKPGKQFASLRAREEVFAALPEQLKKL	186.74	gnl|BL_ORD_ID|2654|hsp_num:0	3501		
BGC0000695.1|Fortimicin_46 # 46148 # 46678 # -1 # ID=1_46;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.763	BGC0000695.1|Fortimicin_46 	46148	46678	-	Loose	300	36.1946	SAT-4	24.68	3002897	protein homolog model	n/a	n/a	nucleoside antibiotic	antibiotic inactivation	streptothricin acetyltransferase (SAT)	ATGCACCGGGCCGCCACCGAACTGCGCCACGACCTGGCGGACCTGCCGATGCCGGCCCCGTTGCCTTCCGGCTGGTCCCTCGCCACGCCCGGCTGGGACGACGACCTGCACGACGCGCTCGTGGCGGCGTACGGGCCGGGACACCCCGACGGTGCCTGGCGCGACGACCACACGGCCCAGGTGCGGGCGATGTTCGACGACGGCGGCCCCGTCCCGCCGCTGCTGCCCGCCTCGGCGCGCGTAGTCGGTCCGGACGGACGGAGCGCCGGCCACGTCCTGTCCACCGGCCCCGCCCCCGACCGGCCCTACGGCTGGGTGGTCAACCTCGGCGTGGCGCCGCGCGCCCAGGGCCGGGGACTCGGCCGGGCCCTGCTCACCCACGCCCTGTACGGCACCCGAACCGCGGACCTCCCCGCGCTCGCCCTCCAGGTCGCCGACGGAAACTCCGCCCGCCGGCTGTACGACGCTGCCGGGTTCCGGCCGGTCAGCCGGATGTTCTCCGTACGGCTAAGGGCGAATCGCGGCCGCTAA	MHRAATELRHDLADLPMPAPLPSGWSLATPGWDDDLHDALVAAYGPGHPDGAWRDDHTAQVRAMFDDGGPVPPLLPASARVVGPDGRSAGHVLSTGPAPDRPYGWVVNLGVAPRAQGRGLGRALLTHALYGTRTADLPALALQVADGNSARRLYDAAGFRPVSRMFSVRLRANRGR	MITEMKAEHLKDIDKPSEPFEVIGKIIPRYENENWTFTELLYEAPYLKSYQDEEDEEDEEADCLEYIDNTDKIIYLYYQDDKCVGKVKLRKNWNRYAYIEDIAVCKDFRGQGIGSALINISIEWAKHKNLHGLMLETQDNNLIACKFYHNCGFKIGSVDTMLYANFENNFEKAVFWYLRF	97.78	gnl|BL_ORD_ID|1523|hsp_num:0	1505		
